WeedVoice

An online media news aggregator and blog for the cannabis and hemp industry world-wide.

Marijuana Stocks PreMarket Update For Monday 11-20-2017

(CRPGF) Breaking News! CNRP Mining Inc (CRPGF) X-SPRAYS Appoints John Knapp as Chief Executive Officer

This morning, (CRPGF) made a BIG announcement. The company announced that X-SPRAYS, subject to regulatory approval, has appointed John Knapp as the new Chief Executive Officer . This is on the heels of its last update where the company’s target, X-SPRAYS announced that it launched a test market for two of its products with a group of Denver, Colorado based medical and recreational marijuana dispensaries.

And here’s what could be a very key piece in today’s news: Mr. Knapp brings over 8 years of experience in the cannabis industry to X-SPRAYS. A pioneer in the legal cannabis industry, John Knapp is a co-founder of PharmaCielo, a Colombian based, internationally focused medicinal-grade cannabis extract company.  Mr. Knapp is also the founder of Colorado-based Good Meds, an award-winning medical cannabis business with a 90,000 square foot cultivation and extraction facility that is vertically integrated via supplying to two dispensaries in the Denver market.

CLICK HERE for the full releaseHave You Connected The Dots?

Bear in mind that CRPGF is our newest Connect the Dots feature. These types of features focus on emerging companies within the marijuana industry that we believe could have longer term potential. We originally debuted (CRPGF) this summer and ever since bringing it to light as our newest Connect the Dots focus, we’ve watched as (CRPGF) continues to climb.

If you have not seen the full Report, CLICK HERE NOWTrending: California Releases Marijuana Regulations for 2018 Sales.

Registered voters in California just last year have legalized the recreational use of marijuana, which will be commencing in 2018, a decision to blend a new market with its matured medical marijuana industry which is forecasted to become a $7 billion Industry, the largest in the U.S. The sunshine state’s highly anticipated regulations regarding the upcoming legal marijuana industry have been released and they may put smaller growers out of business.

CLICK HERE for Full Article

MarijuanaStocks.com is owned by MAPH Enterprises LLC., a Florida Corporation that has been compensated $100,000 by a non-affiliate 3rd party for a 1 year period beginning August 1, 2017 and ending August 1, 2018 to publicly disseminate information about CNRP Mining, Inc. (CND.CN) (CRPGF). We own zero shares. We may buy or sell additional shares of (CRPGF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
0 Comments

Terra Tech Corp. (TRTC) Appoints Alan Gladstone to Board of Directors

Terra Tech Corp. Appoints Alan Gladstone to Board of DirectorsTerra Tech Corp. (TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced Alan Gladstone has been appointed to the Company’s Board of Directors. Mr. Gladstone joined Terra Tech as the inaugural member of the Company’s Advisory Board on August 3rd, 2017 to help provide strategic consulting to the Company. Mr. Gladstone brings decades of experience in the retail sector in which he was the Founder, Chairman, President and CEO of Anna’s Linens, a specialty retailer of home textiles and home decoration items.

“Alan is a leader in the retail sector, with proven business and analytical skills, and we are excited to have him join our Board of Directors,” commented Derek Peterson, Chairman and Chief Executive Officer of the Company. “From the time he started on our Advisory Board, we have seen first-hand the level of operating and leadership experience he brings to Terra Tech. Alan’s addition further strengthens our board’s capabilities and we are confident he will be an asset to the Company as we continue to grow our business.”

“I am pleased to join Terra Tech’s Board of Directors and believe this is a great opportunity for me as the Company enters into the next phase of its business cycle,” stated Mr. Gladstone. “I have admired what Derek and the team have accomplished at Terra Tech and I look forward to contributing to the Company’s future growth and success.”

Mr. Gladstone was Founder, Chairman, President and CEO of Anna’s Linens, a specialty retailer of home textiles and home decoration items, from 1987 – 2015. During his tenure at Anna’s Linens, he grew the business to 305 stores in 23 states with over $400 million in annual revenues. He managed a team of 12 executives and over 3,500 employees and oversaw the company’s M&A strategy. Anna’s Linens was ranked the 13th largest seller of home textiles nationally in 2013. Prior to his time at Anna’s Linens, he was a self-employed retail business consultant where he counted Vons, TG&Y and Cook United in his client base. He was also President of Home Front, a division of U.S. Shoe, from 1983 – 1986 where he led a team of 800 employees. In this role, he led the profitable growth of the business from 21 stores to 105 stores, and grew sales from $40 million to $400 million. Mr. Gladstone has a BS in Economics from the University of California, Irvine.

To be added to the Terra Tech email distribution list, please email  with TRTC in the subject line.

About Terra Tech

Continue reading
0 Comments

Player’s Network, Inc. (PNTV) Reaches Settlement Agreement of Its Lawsuit Against Comcast Corporation

Players Network, Inc. Reaches Settlement Agreement of Its Lawsuit Against Comcast CorporationPlayer’s Network, Inc. ( OTCQB : PNTV ), a diversified holding company, today announces it has reached an out of court settlement of its lawsuit against Comcast Corporation ( NASDAQ : CMCSA ).

In early 2014 Players Network filed a complaint against CMCSA, which has been recently settled, the terms of which are confidential, and puts an end to the dispute over Players Network’s Vegas On Demand Television Network.

PNTV was a pioneer in the creation of Vegas On Demand which was one of the first independently owned VOD networks on CMCSA’s Video On Demand platform and ran from April 2004 through November 2015. The Vegas Gaming and Lifestyle Network also gained distribution on virtually every major cable network, OTT and Satellite platforms including, but not limited to; DirecTV, Dish, AT&T U-verse, Verizon Fios, HULU and Google Video.

“Despite this lawsuit, we were grateful for the opportunity to expand our programming and create a better business model for monetizing digital, interactive networks,” said PNTV CEO Mark Bradley. Bradley continued “this experience pushed us to reinvent our self as a company, and expand our platform and technology in a way that I believe will become the standard and outperform any new network in both viewership and revenues.”

Michael Berk, Board Member and Chief Creative Officer states; “I believe the business model we developed for our new networks will change the way new networks are developed and specifically how they conduct their business models.”

To sign up for PNTV investor alerts, please visit: https://ir.playersnetwork.com/investor-alerts

Continue reading
0 Comments

CNRP Mining Inc (CRPGF) X-SPRAYS Appoints John Knapp as Chief Executive Officer

X-SPRAYS Appoints John Knapp as Chief Executive Officer

CNRP Mining Inc. (CSE:CND) (CRPGF) (the “Company” or “CNRP Mining”), is pleased to announce that X-SPRAYS, subject to regulatory approval, has appointed John Knapp as the new Chief Executive Officer effective immediately.

Mr. Knapp brings over 8 years of experience in the cannabis industry to X-SPRAYS. A pioneer in the legal cannabis industry, John Knapp is a co-founder of PharmaCielo, a Colombian based, internationally focused medicinal-grade cannabis extract company.  Mr. Knapp is also the founder of Colorado-based Good Meds, an award-winning medical cannabis business with a 90,000 square foot cultivation and extraction facility that is vertically integrated via supplying to two dispensaries in the Denver market.

(CRPGF) Full Profile Here

Mr. Knapp is experienced in the design and operation of cGMP grade cannabis cultivation and extraction facilities. His ‘smart design’ approach to the industry has been featured on the television news magazine “60 Minutes”. Under Mr. Knapp’s direction, the company evolved from a single-caregiver/wholesale operation to a thriving business with over 65 employees, designing and implementing seven commercial cultivation facilities in four years as well as a state of the art extraction processing and analysis laboratory.

Mr. Knapp holds a Bachelor of Science in Industrial Engineering from Western Michigan University.

“I look forward to working with the X-SPRAYS team and bringing my knowledge and experience in the international cannabis sector to help accelerate the go-to-market strategy and refine back end production, procurement and operations,” said Mr. Knapp.

Continue reading
0 Comments

California Releases Marijuana Regulations for 2018 Sales

Registered voters in California just last year have legalized the recreational use of marijuana, which will be commencing in 2018, a decision to blend a new market with its matured medical marijuana industry which is forecasted to become a $7 billion Industry, the largest in the U.S. The sunshine state’s highly anticipated regulations regarding the upcoming legal marijuana industry have been released and they may put smaller growers out of business.

The regulations have been in discussion for quite some time. Temporary licenses for growers, distributors, and retailers will be issued by the state on Jan. 1, when sales become legal, provided that these companies have business permits to operate. The regulations cover everything from licensing fees to standards for testing, growing and distribution.

Regarding marijuana farms, deciding on size limitations was debated heavily. The state had previously indicated a maximum 1-acre limitation that would be established for cultivators. Yet, Thursday’s regulations placed limits only on certain medium-sized growers’ licenses. Other than that, “there is no limitation for the other categories of licenses,” said Steve Lyle from state Department of Food and Agriculture.

Hezekiah Allen, of the California Growers Association, interpreted that the regulations give the impression that large businesses will be able to acquire “as many licenses as they could afford,” which would lead to overproduction and threaten the sustainability of the smaller farms. The annual fees for cultivation licenses are based on production and can range anywhere from $1,200 to $80,000. California “could have just opened the door for well-capitalized interests … to really jeopardize the success of the marketplace,” Allen said.

Overall, California marijuana will be treated just like alcohol. Adults 21 and older will be able to legally retain up to an ounce and also be able to grow six marijuana plants at home. The state is expecting to generate close to $1 billion in new taxes over the next few years.

Continue reading
0 Comments

Top 3 Pure-Play Marijuana Stocks

It has been a green year for marijuana stocks as some have rallied over 100% as sales growth for legal marijuana continues to increase. The marijuana industry has changed rapidly as the perception of marijuana continues to be viewed in a more positive light than ever before, which is budding the pockets of investors.

An increased number of marijuana stocks possess market caps over $1 billion which continues to make the marijuana market more attractive to investors. Here are the top three pure-play marijuana stocks in terms of market cap.

Canopy Growth Corp (TWMJF) $3.02 billion

Canopy Growth is the king of marijuana stocks and has the highest individual market share in the thriving Canadian medical marijuana market. The company has just reported second quarter earnings showing a massive 107% increase in revenue from the year prior. The deal Canopy achieved with Fortune 500 Constellation Brands (STZ), which invested $245 million for a 9.9% stake into the company for collaboration of marijuana infused beverages was a game changer for the industry.

Canopy continues to expand its growing operations as Canada’s national legalization of recreation marijuana can add billions to its revenue. The company isn’t just expanding domestically either but abroad as well adding to its list of countries where it exports its medical marijuana such as Spain, Jamaica, Denmark, Germany.GW Pharmaceuticals (GWPH) $2.84 billion

Continue reading
0 Comments

Marijuana Stocks PreMarket Update For Friday 11-17-2017

CNRP Mining (CRPGF) – Connect The Dots Keeping Up The Pace

(CRPGF) was introduced earlier this summer as a company to watch. At that point it was on the heels of several key breakthroughs for a new business direction and as we’ve seen, the company has continued to execute on its plan. It wasn’t until just a few weeks ago that (CRPGF) became our newest Connect The Dots Feature and ever since then, (CRPGF) has been nothing short of exciting.

Over the last few weeks we’ve seen this company make key announcements and the market has rallied. Being that this is such an early stage company, there could be potential for more catalysts along the way. As the stock has held a trading channel between $1.20-$1.30, this could be another “calm before the storm.” Of course, we’ll be monitoring this very closely. If you haven’t had a chance to get familiar with (CRPGF), click here: Connect The Dots: CNRP Mining Inc. (CRPGF)

POTN Runs After Latest Records Being Broken

Potnetwork Holding (POTN) has been a company that we’ve been watching for months. Big momentum helped this run to highs of almost $0.10 earlier in the summer and since then, we’ve seen (POTN) consolidate to levels around 0.055. But what has happened over the last few weeks has been nothing short of impressive in our opinion because it’s all about growth with (POTN).

Not only did the company set new records for its quarterly results (Reported over $4m for the third quarter), but also yesterday (11-16) the company announced rock solid MONTHLY figures for October. (POTN) rang in with nearly $1.7 million, which surpassed September’s results by more than 40%! These numbers aren’t something that you see regularly from marijuana companies!

Right now may be an important time to be looking at this company because not only has its chart broken above a critical technical point on the chart but it did so on much more than average trading momentum. This could signal a turning point for (POTN) and it’s also important to note that the company has engaged the auditing services of East West Accounting Services, LLC, to provide a methodical review and analysis for the audited verification of the Company’s recent monthly reported revenues. This would be a big step forward when it comes to transparency for the public and something that experienced investors like to see.

Continue reading
0 Comments

The Game Changing $3 Billion Marijuana Stock Merger

Canopy Growth Corporation (TWMJF) may not have been holding onto the title of purest play marijuana stock with the highest market cap for as long as we might have thought. This week, Aurora Cannabis (ACBFF) announced the submission of a proposal for the purchase of another Canadian marijuana grower, CanniMed Therapeutics, which trades on the Toronto Stock Exchange at $24 per share. If the deal is signed, the combination of the two companies will surpass a market cap of $3 billion taking over the title as the new champion of marijuana stocks.

With this acquisition, Aurora’s active medical marijuana patients would total over 40,000 and CanniMed’s customers would gain access to Aurora’s e-commerce platform allowing online purchasing. The most important part of the acquisition for Aurora would be the increased capacity equating to five cultivation facilities and more in the works.

All in all, this would generate annual production of around 130,000 kilograms of marijuana which is key to Canadian growers who will be facing high product demands as national legalization approaches. With the legalization of recreational marijuana in the country, the cultivation industry should be large enough support multiple top dogs which may initiate more mergers and acquisitions to follow suit of Aurora.

The main reason we may see this deal signed is that Aurora has obtained “irrevocable lock-up agreements” with shareholders that possess about 38% of CanniMed’s outstanding shares. What does this mean? The agreement entails that those shareholders must vote against any other possible acquisitions that would hold back Aurora’s efforts of purchasing CanniMed. Although that is not the majority vote, there isn’t much in the way for Aurora.

There is always the possibility that merger will not take place. We will just have to continue to watch the booming marijuana market closely.

Continue reading
0 Comments

NYSE Adds Marijuana EFT

With twenty-nine states and the District of Columbia having legalized medical marijuana along with the eight states plus and D.C. legalizing recreational as well financial institutions are finally making their way into the nation’s forecasted $8 billion industry. A division of the New York Stock Exchange is launching trading for its first marijuana fund the day after Christmas. What does this mean for investors?

The fund dubbed, Alternative Argoscience exchange-traded fund (ETF), is made up of companies that operate in states where marijuana has been legalized. The companies include cultivators, biopharmaceutical companies, even pesticide and fertilizer companies. Neither the NYSE, Justice Department, or the EFT Managers Group responded to the requests for comments.

Although, the marijuana fund is spanking new to the United States, it’s not unparalleled. In April, our neighbors up north launched the first ever marijuana EFT in the world. Canada’s marijuana EFT has increased by 44 percent since its introduction and gained $216 million in assets.

Steve Hawkins, CEO of Horizons ETFs stated that in Canada the marijuana industry is thriving. The country is on target to fully legalize marijuana nationally by July and the Canadian financial markets have commenced investment into the budding industry.

“We would love to launch a product in the U.S.,” Hawkins said. With even medical marijuana remaining federally illegal in the U.S., it is holding Hawkins back from making any moves. Hawkins added, “With the current government you have in place, they just don’t care. They really have no interest in looking at the cannabis capital markets from that perspective”.

Continue reading
0 Comments

Marijuana Stocks Must Read Breaking News & Articles – November 16, 2017

GT Biopharma, Inc. (GTBP) Announces Shawn M. as President and Chief Operating Officer

GT Biopharma, Inc. (GTBP) (GTBP.PA) (“GT” or the “Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments, today announced that Shawn M. Cross has accepted the position of President and Chief Operating Officer, effective immediately.

Click Here for Full Release

(CRPGF) Continues To Trend Higher

By now many of you know that our new Connect The Dots Feature is (CRPGF). We’ve seen this emerging MJ Stock soar to highs of nearly $2 after running 417% within just a few weeks. Now we could be starting to see a new trend in the making as (CRPGF) has continued to trend higher after consolidating earlier in the month. As (CRPGF) consistently sees higher highs & higher lows, many have started to pay attention once again to this company heading into the second half of the month! Click the link below to access full report!

Continue reading
0 Comments

Reliq Health Technologies Inc. (RQHTF) Reaches over 2,000 Patients Live on Its iUGO Care Platform

Reliq Health Technologies Reaches over 2,000 Patients Live on Its iUGO Care PlatformReliq Health Technologies Inc. (RHT.V) or (RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) solutions for Community-Based Healthcare, is pleased to announce that it now has over 2,000 paid subscribers using its iUGO Care chronic care management, remote patient monitoring and telemedicine platform, representing recurring monthly revenue of over US$100,000/month.

“We are excited to announce that we now have over 2,000 patients live on our iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health.  “The onboarding of patients is starting to accelerate as we move forward with our roll out to over 40,000 patients in Texas. We expect to continue to enrol more than 1,000 new patients per month through 2018 with our two contracts with Paz Home Health, LLC (Pharr, TX) and Rio Grande Valley Health Alliance, LLC (McAllen, TX), which together are worth over US$26 Million annually in recurring revenue at full deployment.  We are proud to offer a solution that comprehensively and cost-effectively addresses the needs of front line care providers in the community and the more than 37 Million Medicare and Medicaid patients who have two or more chronic conditions.”

Reliq is also pleased to announce that it has launched a new version of its corporate website, incorporating improved functionality and expanded content. The site will allow visitors to gain a comprehensive understanding of Reliq’s business model and provide an industry-leading resource for information on the Community Healthcare market.

Reliq’s iUGO Care digital health solution provides high-quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and tracking medication adherence. iUGO Care’s interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities.  iUGO Care’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions.  Reliq’s iUGO Care cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

Continue reading
0 Comments

GT Biopharma, Inc. (GTBP) Announces Shawn M. as President and Chief Operating Officer

GT Biopharma, Inc. Announces Shawn M. Cross, 20-Year Healthcare Investment Banking Industry Veteran, as President and Chief Operating OfficerGT Biopharma, Inc. (GTBP) (GTBP.PA) (“GT” or the “Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments, today announced that Shawn M. Cross has accepted the position of President and Chief Operating Officer, effective immediately.

Mr. Cross is an internationally recognized investment banker specializing in the biopharmaceutical sector with over 20 years of experience. He was most recently Managing Director, Head of Biotechnology Investment Banking at Deutsche Bank Securities Inc. Previously, he served as Managing Director and Head of Biopharmaceutical Investment Banking at Wells Fargo Securities, LLC.

Mr. Cross began his career at Alex. Brown & Sons Inc. after receiving his M.B.A. with a concentration in Finance from Columbia Business School. He received his B.S. from University of California, Los Angeles and prior to business school worked in Brian Reid’s lab at the University of Washington Medical School, Division of Gastroenterology, where he worked on a team studying the role of p53 in neoplastic progression.

GT Biopharma Executive Chairman Anthony J. Cataldo said, “The addition of Shawn to our executive management team is important to continuing to advance the accomplishments we have achieved throughout this year. Shawn’s experience in advising publicly traded emerging biotech companies, in key strategic arenas, provides timely expertise at this stage of the Company’s growth and serves as a major milestone for the Company.”

GT Biopharma Chief Executive Officer Dr. Kathleen Clarence-Smith said, “Shawn and I have known each other for many years, and I have been impressed by his accomplishments in healthcare investment banking. His past experience in both biomedical research and finance should be of great value to the Company. He brings a clear vision and strong leadership skills to GT Biopharma. I look forward to working with Shawn on our continued growth.”

GT Biopharma President and COO Shawn M. Cross said, “I see a great deal of promise in GT Biopharma’s pipeline of immune-oncology and neurology therapeutics and am delighted to become part of its skilled leadership team. GT Biopharma is a dynamic company with a potentially ground-breaking oncology platform technology and diverse portfolio, and I look forward to being instrumental to the evolution of such an exciting and diverse company.”

Continue reading
0 Comments

PotNetwork Holding, Inc. (POTN) Reports Revenues of $1,694,788 for October

PotNetwork Holding, Inc. Reports Revenues of $1,694,788 for October, Surpassing September Results by over Half a Million Dollars

PotNetwork Holding, Inc. (OTC Pink: POTN) announced today, it’s wholly owned subsidiary, Diamond CBD, Inc., has reported its revenues for October. With nearly $1.7 million generated, the Company’s sales exceeded September’s revenues by 42%.

“It’s exciting that our sales continue to strengthen. With our continuing strategy in place, we approach the end of the year with great anticipation,” stated Chief Executive Officer, Richard Goulding, MD.

PotNetwork recently announced that the Company had recently reported Third Quarter Revenues of $4,444,800.00, exceeding Second Quarter Results by 29%. The Company also retained the auditing services of East West Accounting Services, LLC, a Public Company Accounting Oversight Board (PCAOB) registered CPA firm, to provide a methodical review and analysis for the audited verification of the Company’s recent monthly reported revenues.

About Diamond CBD, Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holding, Inc: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Continue reading
0 Comments

Tetra Bio-Pharma Inc. (TBPMF) Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner AphriaTetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps™, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. (“Aphria”) under Access to Cannabis for Medical Purposes Regulations (ACMPR).

Based on the most recent ACMPR market data from the Government of Canada, it is estimated that the sales of dried medical cannabis in Canada from April 2017 to March 2018 will be over $188M; Tetra is now entering this lucrative market and plans on progressively grabbing a significant share of it over the next two years. Mr Fortier, CEO of Tetra, stated last week “We are expecting to generate around $1.5 million in sales, in fiscal 2018 in our initial launch. Through our promotion and education efforts in Quebec, New Brunswick and part of Ontario, we estimate that over eight thousand patients will start using Rx Princeps™ under prescription from their doctors over in the next twelve months.”

Rx Princeps™ is a new option for doctors who want to prescribe medical cannabis. Prescribing Rx Princeps™ with the Rx Princeps™ inhalation device enables their patients to optimize the benefits of medical cannabis through the intake of a fixed dose of product, thereby ensuring consistency of treatment with a standardized high-quality product.

Aphria grows and produces medical cannabis under a strict quality management program. Tetra chose Aphria as its partner because their production processes were adopted from the highly restricted and regulated pharmaceutical industry, and go above and beyond cannabis industry regulations mandated by Health Canada. As a result, Aphria’s products are in line with the strict quality standards Tetra is establishing for the medical community and its patients.

200,000 patients are already registered under the ACMPR program and around 1.5 million adults in Canada suffer from chronic pain and are considered non-responders to opioids; medical cannabis could be a new therapeutic choice for those patients but physicians need bioavailability and safety data to prescribe medical cannabis with confidence. According to Health Canada, less than 3,000 physicians actually prescribe cannabis to their patients. Tetra is committed to provide them rigorous safety and bioavailability data. Tetra has begun educating pain clinics and the medical profession across Canada on Rx Princeps™, including its advantages for patients.

In Quebec, Tetra is working closely with Sante Cannabis in order to educate patients and support them in their medical journey with cannabis. Sante Cannabis is the first cannabinoid clinic and medical marijuana resource centre in Quebec.

Continue reading
0 Comments

InMed Pharmaceuticals, Inc. (IMLFF) Present at Cannabis-Based Science & Medicine Conference

InMed to Present at Cannabis-Based Science & Medicine ConferenceInMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE:IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today it will present at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference on Thursday, November 30th and Friday, December 1st, 2017 in Denver, CO.InMed Pharmaceuticals Inc. (CNW Group/InMed Pharmaceuticals Inc.)

Dr. Sazzad Hossain, InMed’s Chief Scientific Officer, will be presenting a lecture entitled “Epidermolysis to Glaucoma – Identifying Pathology Candidates for Cannabis-Based Treatments.” This presentation will highlight InMed’s internal process of identifying disease targets for treatment with therapeutic cannabinoid compounds, developing tissue-specific delivery formulations, and innovative approaches to addressing regulatory challenges with cannabinoid-based therapies.

More information on this conference, organized by CBI – a division of UBM, is available at: http://www.cbinet.com/conference/pc17091

About InMed

InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics platform, its biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the Company. For more information, visit www.inmedpharma.com.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Continue reading
0 Comments

Green Cures & Botanical Distribution, Inc. (GRCU) announce a successful showing at “High Times Harvest Cup”

Green Cures & Botanical Distribution, Inc. And Purple Haze Properties announce a successful showing at “High Times Harvest Cup”

Green Cures & Botanical Distribution, Inc. ( OTC PINK : GRCU ) are pleased to announce a successful showing of all our products at the High Times Harvest Cup this past weekend. Our product lines were widely embraced by attendees and industry partners alike. We are looking forward to having our products placed dispensaries throughout California.

With the holiday’s quickly approaching, we will be offering discount pricing on the Hollywood Hemp product line which is currently available for sale on our website. This discount pricing will allow you to stock up for the holidays or try something new.

We have finalized our agreement with the new CEO and are very confident with the Cannabis knowledge and industry background he brings with him. This will insure that Green Cures is properly poised to take on the vast influx of products we will offer this upcoming year.

Purple Haze Properties, LLC was founded through a partnership between Andrew Pitsicalis and Leon Hendrix, blood brother to the legendary guitar icon Jimi Hendrix. Purple Haze Properties, LLC is the premiere source for Jimi Hendrix cannabis related products as well as a premiere celebrity licensing company for the Cannabis Industry. We represent Cannabis Licensing for many celebrities including Jimi Hendrix, Digital Underground, Janes Addiction, Money B, The Emperor of Hemp, Jack Herer and others. Purple Haze Properties participates in all aspects of the cannabis industry including Licensing, Social Media, Medicinal, Music and Entertainment areas. Check us out at www.purplehazeproperties.com or www.facebook.com/purplehazeproperties.

About Green Cures & Botanical Distribution, Inc. ( OTC PINK : GRCU )Green Cures & Botanical Distribution Inc., is revenue-generating company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production to distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy lifestyle. For more information visit: http://www.grcustock/.

Continue reading
0 Comments

5 CBD Stocks To Watch In November

There’s no denying that marijuana is one of the fastest growing industries throughout the U.S. and Canada. Companies are thriving within this marketplace regardless of the federal regulations and the fight against mass legalization. Guess what, a good majority of these companies are publicly traded, meaning people can invest in them. The businesses in the marijuana industry range from, management software for dispensaries or biotech companies to businesses that sell CBD products and hemp-based edibles.

In fact, according to Forbes, the cannabidiol (CBD) market is anticipated to grow by an impressive 700% by 2020. A recent report by Hemp Business Journal estimates that the CBD market will advance to $2.1B by 2020.

One big catalyst why CBD’s products are a hot product for marijuana companies, is that CBD comes from hemp, and hemp is legal to import and purchase in all 50 states across the United States with no federal restrictions. This has opened up a window of opportunity for companies that are operating within the marijuana industry to be able to capitalize on this rapidly growing market.

This key driver has also caught the attention of investors who are looking for a place to put their money into a marijuana stock that is selling CBD products. Since the start of this year we have seen a surge in the marijuana stock market that have investors excited for what’s to come in the future for this untapped industry. With that being said, here are 5 CBD stocks to watch in November.

PotNetwork Holdings, Inc. (POTN)

This marijuana stock operating within the rapidly growing CBD industry is not only operating but also thriving. The company recently reported record breaking third quarter revenues exceeding $4.4 million, surpassing the previous quarter by 29%. This also brings its total revenue for the first 9-months of the fiscal 2017 to over $9.5 million.

Continue reading
0 Comments

San Francisco Undecided on Recreational Marijuana Rules

To be ready for the commencement of marijuana sales on January 1st, the board needs to vote on temporary regulations. But, the supervisors in San Fran are having a hard time agreeing on the placement of recreational stores as opponents are voicing concerns. The board will resume marijuana regulations following the Thanksgiving holiday.

Many of the opponents are older Chinese immigrants who oppose marijuana use in general and are fighting to limit it will be sold. Chinese-Americans play a vital role San Francisco’s history and one-third of the city’s 850,000 residents are Asian and Chinese-Americans, as well as the mayor.

The divided board supervisors may vote on a stop-gap measure to permit the sale of recreational marijuana through current medical marijuana outlets while they continue to work out what locations are acceptable for new stores.

“Let’s be honest: Cannabis is effectively legal now and the sky hasn’t fallen. A lot of the information people have been given is completely false,” stated Supervisor Jeff Sheehy, who is a user of medical marijuana for the alleviation of pain. Sheehy is proposing to keep a 600ft distance from schools which mirrors the radius of stores that sell liquor or tobacco.

Some Chinese-American organizations are fighting for a total prohibition of retail stores in the city’s Chinatown and seeking stores to be at minimum 1,500 feet away from schools. Supervisors are considering a 1,000-foot radius that marijuana advocates believe is too restrictive for the compact city. Keep in mind, medical marijuana dispensaries are required to be at least 1,000 feet away from schools and minor recreation centers.

Continue reading
0 Comments

New Rules and Regulations For Legal Marijuana

New tax rules for legal marijuana which will go into effect January may raise prices but most likely will not reduce marijuana use, said several policy experts and dispensary staff.

Registered voters of California approved Proposition 64 back in November 2016, allowing residents of the sunshine state over the age of 21 to possess up to one ounce of marijuana and grow up to six plants. The proposition also allows businesses to sell marijuana starting in January.

Steven Davenport, a UCLA alumnus and policy researcher for the RAND Corporation, a think tank based in Santa Monica, said he thinks marijuana prices will rise during its first year of legalization.

Davenport, who has worked on the Liquor and Cannabis Board in the state of Washington, which legalized marijuana in 2012, added he thinks prices will drop once the market stabilizes.

“In Washington, for example, prices started as high as $25 per gram because the state did not start with enough growers and did not have enough supply,” Davenport said.

Continue reading
0 Comments

Marijuana Stocks: This Industry Is Growing Like A Weed! – November 15, 2017

(CRPGF) Pattern Showing New Trend?

We’ve now seen our newest Connect The Dots Feature, (CRPGF) go on a monster run during the last few weeks. Percentage moves of 417% and highs of nearly $2 have begun to put this company on the radar of the street. After recent consolidation, could there be new potential on the horizon?

The company has continued to release key developments over recent weeks and right now it could all come down to timing! This is also in light of the recent news about (CRPGF)s target, X-SPRAYS™ has just launching a test market for two of its products with a group of Denver, Colorado based medical and recreational marijuana dispensaries. Click the link below to access full report!

Click Here for Details

Quarter 2 Results Are Out and This Marijuana Stock Continues to Grow Like A Weed

Continue reading
0 Comments

Future Farm Technologies Inc. (FFRMF) Sets Closing Date on 120-Acre Licensed Industrial Hemp Farm

Future Farm Sets Closing Date on 120-Acre Licensed Industrial Hemp Farm

Future Farm Technologies Inc. (the “Company” or “Future Farm”) ( CSE : FFT ) ( OTCQB : FFRMF ) is pleased to announce the closing date of November 28, 2017 for its previously announced acquisition of a 120-acre industrial hemp farm in Amity, ME. With this acquisition, Future Farm is now strategically positioned in both the fast-growing hemp market as well as the cannabis market.

The Company is also actively looking for additional land in Maine on which it may grow hemp, in addition to the aforementioned 120-acres. Future Farm expects to harvest 1,700 plants per acre of the 120-acre farm, which translates into approximately 10 kilos of CBD distillate per acre. Current prices for CBD products vary, but the majority of CBD products fall within the $9-12 per gram range. With 120-acres under contract, and with the possibility of acquiring additional farmland, Future Farm is anticipating a significant increase in 2018 revenue from CBD oil sales.

“This is a strategic acquisition for us as we look to leverage our oil extraction techniques into the CBD business,” comments Bill Gildea, CEO of Future Farm. “We are pleased to be working with Derek Ross and his team of experienced growers, and we look forward to adding value by installing new state of the art CBD oil extraction equipment on-site to meet the exploding demand of CBD oil worldwide.”

Derek Ross, CEO of Cannatech, comments, “I’m excited to grow this business with Future Farm. Partnering with a public company allows us to scale this business faster by enabling us to process large amounts of hemp flower into highly pure CBD concentrates.” Mr. Ross continues, “We are actively looking for more land to acquire so that we may rapidly scale production as the market demand for CBD oil continues to expand.”

The total domestic value of hemp retail products sold in 2015 was $573 million, according to the Hemp Industries Association. In addition, the U.S. annually imports $500 million of hemp and hemp-related products. The nutraceutical active ingredient global market is $20 billion per year, while the pharmaceutical active ingredient global market is $13 billion per year.

Continue reading
0 Comments

International Consolidated Companies, Inc. (INCC) enters the Pet Market with Canine CBD Chill Pill

BluDog Products enters the Pet Market with Canine CBD Chill PillBluDog Products LLC, a subsidiary of International Consolidated Companies, Inc. (INCC), enters the Pet Market with Canine CBD Chill Pill.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/dd44749a-7de7-43b8-9329-1f10441fa7f2

According to data kept by cannabis industry analytics firm MJ Freeway, it’s the newest trend in America’s booming half-billion dollar animal supplements market, which is expected to grow by more than $150 million in the next four years.

CBD is one of over 80 active cannabinoid chemicals in marijuana, according to the National Institute on Drug Abuse. Unlike tetrahydrocannabinol (THC), CBD doesn’t create a euphoric sensation. In other words, these biscuits won’t get your dog high.

Academic research about CBD’s effect on animals is nearly nonexistent, and the Food and Drug Administration has not approved marijuana use in animals. Despite this, some veterinarians recommend their use, and producers say pet stores are increasingly beginning to carry CBD treats.

“I’m excited BluDog is entering this growing space,” Antonio Uccello said. “There are so many pet owners that would do just about anything to relieve their animals suffering.”

Continue reading
0 Comments

GB Sciences, Inc. (GBLX) Exceeds Its Gross Revenue Projections for October

GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield Per Active Flower LightGB Sciences, Inc. (GBLX) announces that it has exceeded the October gross revenue projection of $500K from the sale of premium flower by 2%. Gross sales projections for the month of November are also trending in this direction.

The GB Sciences cultivation facility has 180 active flower lights for plant cultivation and grows in a clean room-like environment. The industry standard yield is approximately one and one-half (1.5) pounds yield per flower light (of cured, untrimmed flower).  GB Sciences yield is about three pounds of yield per flower light.

The COO Kevin Kuethe explains, “Our state-of-the-art modern growing facility and techniques create and control the growing environment.  Inside that environment, our growers bring a deep experience and understanding of the plant.  The combination of a state-of-the-art precision growing environment and having a dedicated and harmonious team operate that environment, enables us to consistently produce yields that are double the industry average.”

Kevin Kuethe added, “Our custom concentrated nutrient blends are a key element in the process.  After all, it is the nutrition that keeps the plants healthy, and each strain eats a little different blend of nutrients to maximize the genetic potential of each of our strains.  Because we measure and monitor the exact amounts of every aspect of the plant’s life, we can scientifically determine how to maximize the yields.  We operate our precision controlled growing environments for maximum consistency, quality and yield.”

GB Sciences, Inc.GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.

Forward-Looking StatementsThis press release may contain statements relating to future results or events, which are forward-looking statements.  Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control.  It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements.  Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov.  All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.Note:  Although the Company’s research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist.

Continue reading
0 Comments

Quarter 2 Results Are Out and This Marijuana Stock Continues to Grow Like A Weed

Canopy Growth (TWMJF) is notably the largest and diversified marijuana company in the market and today it reported the highly anticipated results for the second quarter. As expected, the company continues to grow and holds the title or the largest marijuana stock on the market.

The company’s second-quarter revenue doubled from last year’s equating to $17.6 million. This is a massive 107% increase from 2016’s second quarter of $8.5 million. Revenue ending September 30th equaled $33.4 million which more than doubled the $15.5 million from the previous year. What has contributed to the company’s undisputed success?

Canopy Growth could be profitable solely from its medical marijuana production. The company sold 2,020 kilograms showing a solid 73% increase over second quarter fiscal 2017 a year-to-date, it has sold 3,850 kilograms at an average price of $7.98 per gram compared to last year’s 2,153 kilograms at an average price of $7.05 per gram.

Canopy continues to acquire more growing property to supply demand. During Q2 it announced the construction of a new greenhouse in Ontario as well as the acquisition of another nearby to increase the total area of Tweed Farms to over 1 million sq. ft.

The company continues to build on its international ventures. In September, Canopy and its subsidiary Spektrum Cannabis GmbH announced a license agreement with Spain’s Alcaliber, S.A., granting Alcaliber the license to utilize specific strains and seeds for cultivation for worldwide sales. Canopy also announced in September that it established a partnership in the Danish market with Spectrum Denmark ApS, a joint venture to supply Danish medical marijuana patients.

Continue reading
0 Comments

Opioid Commission Fights Marijuana Legalization

New Jersey Governor, Chris Christie was appointed in March as the Head of the Opioid Commission by President Donald Trump. Recently, a report was written to Trump by Christie regarding the nation’s opioid crisis, but it also incorporated the “dangers” of marijuana.

The legalization of marijuana is a hard sale for the Commission, as quoted by Christie due to the “lack of sophisticated outcome data” about marijuana being the primary reason as well as the “lack of data” regarding dosing and the potential for abuse and dependency.

In the report, Christie cited a specific study conducted by the National Institute of Health’s National Institute on Drug Abuse which concentrates on the idea that marijuana is a gateway drug. Christie stated that the study “found that marijuana use led to a 2 1/2 times greater chance that the marijuana user would become an opioid user and abuser.” In which he added, “The Commission found this very disturbing”.

The statistic used cited about marijuana users having increased odds of becoming addictive to opioids is over a decade old. Dr. Mark Olfson, the study’s leader, performed the study more recently and he acknowledged that it has shown significantly different results.

Christie isn’t known for being the most truthful man in politics which can indicate that his report may be a tad misleading. There isn’t an absence of data regarding its potential for abuse, instead there is an immense amount of studies indicating marijuana does not possess addictive properties. A recent study has proven that marijuana usage does not alter the brain’s structure in a negative way as alcohol does. Even Dr. Oz has said that marijuana was an exit drug rather than a gateway drug.

Continue reading
0 Comments

It’s All About Timing – CRPGF Update

(CRPGF) was introduced earlier this summer as a company to watch. At that point it was on the heels of several key breakthroughs for a new business direction and as we’ve seen, the company has continued to execute on its plan.

It wasn’t until just a few weeks ago that (CRPGF) became our newest Connect The Dots Feature and ever since then, (CRPGF) has been nothing short of exciting.

Since the first debut on Connect The Dots, (CRPGF) has managed to run as high as $1.98 from $0.3829; that’s a run of 417%! Of course after such a huge run, there was consolidation expected and unlike many other big runners in the space, (CRPGF) has not broken down.

Rather, we’ve now seen (CRPGF) begin to hold support levels above $1. Tuesday (11-14) (CRPGF) even held a channel between $1.20 & $1.27 for most of the afternoon.

MarijuanaStocks.com has always made it a point to stay far ahead of the curve. When we see a hint of opportunity, we make sure to look into it and then focus on all angles of potential that could come with it. For (CRPGF) that angle has everything to due with X-Sprays in our opinion & here’s an overview of several keys to pay attention to:

Continue reading
0 Comments

Marijuana Stocks PreMarket Buzz – Tuesday November 14, 2017

Just The Beginning For (CRPGF)?

(CRPGF) is our newes Connect The Dots feature and with the track record we’ve seen from our previous Connect The Dots Updates, this could be just the beginning!

We’ve watched this early stage CBD company go on explosive runs over the last few weeks and hit highs of nearly $2. After recently consolidation from a run of more than 400%, could there be new potential on the horizon? Marijuana investors continue to see an increase in popularity in the CBD (cannabidiol) market through new product development and research and nutraceutical science has begun to emerge as another big driver for this market segment.

With major developments that have happened with the company’s X-Sprays agreement, timing could become very important right now especially considering X-SPRAYS™ has just launched a test market for two of its products with a group of Denver, Colorado based medical and recreational marijuana dispensaries! If you haven’t gotten familiar with (CRPGF) yet, click the link below!

Click Here for Details

Continue reading
0 Comments

MJ Holdings, Inc. (MJNE) Announces Definitive Agreement to Acquire Red Earth

MJ Holdings Announces Definitive Agreement to Acquire Red Earth; Paris Balaouras to Assume CEO RoleMJ Holdings to acquire Red Earth, a holder of a provisional cannabis cultivation license  in Las Vegas, Nevada.All-stock transaction; Red Earth unit holders will receive approximately 52.7 million common shares of MJ Holdings.

MJ Holdings, Inc. (MJNE), a member of the Bloomberg “Weed Index” announced today that it has entered into a definitive agreement to acquire Red Earth LLC, a Nevada company that holds a provisional license to grow cannabis in Las Vegas, Nevada. The transaction is expected to close during the fourth quarter of 2017, subject to certain approvals and closing conditions.

In connection with the acquisition, Paris Balaouras, Manager of Red Earth, and a seasoned entrepreneur, will serve as CEO of the combined company and will assume the role of Chairman of the Board upon the close of the transaction. Mr. Balaouras, will guide MJ Holdings as the company seeks to develop operations in the Las Vegas market, which legalized recreational cannabis earlier this year.

“This acquisition is a major milestone for MJ Holdings, as we seek to capitalize on the city’s agritourism industry; with over 52 million annual visitors, Las Vegas is the perfect hub from which to build and develop brands and business extensions as legalized cannabis spreads to different states and countries” said Paris Balaouras, MJ Holdings’ newly appointed Chief Executive Officer.”

Adam Selkin, an advisor to the company, CEO of SLee 3 Consulting and a former investment banker, said, “I’m extremely excited to be part of this combined company and Paris Balaouras is the perfect manager to execute the company’s business strategy; and with the recent investment by constellation brands into canopy growth, the public markets are starting to understand the value of a dominant cannabis brand in the market place.”

Forward Looking Statements

Continue reading
0 Comments

Endexx Corporation (EDXC) Lands Award for Best Advancements in Hemp Industry at Uptick Newswire’s Uppie Awards

Endexx Lands Award for Best Advancements in Hemp Industry at Uptick Newswire’s Uppie AwardsEndexx Corporation ( OTC PINK :EDXC ), a provider of innovative phyto-nutrient based food and nutritional products, is pleased to announce that it has been awarded “Best Advancements in the Hemp Industry” at Uptick Newswire’s Uppie Awards. The Uppie Awards honor companies in the Technology, Medical, Bio-Tech, Pharma, Energy, and Cannabis categories.

One of Endexx’s best-selling products is from its pet line, Phyto-Bites®, a CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. A multi-billion dollar market opportunity, CBD products are now popularized in treating animals with everything from anxiety to allergies, epilepsy and support for cancer treatments, and FOX news recent coverage highlighted the increased treatments of medical marijuana for pet illnesses. For full coverage please visit: http://www.fox10phoenix.com/news/arizona-news/pot-for-pets-medical-marijuana-role-in-treating-pet-illnesses

“What an honor it was to be awarded this prestigious title alongside many significant companies within the emerging hemp industry,” said Todd Davis, CEO of Endexx. “We have made tremendous accomplishments over the past few quarters with our products launches and sales efforts, and look forward to another great year ahead.”

The Uppie Awards are produced by Uptick Newswire, and its attendees include micro-cap investors, boutique hedge-fund managers, and other investors as well as local and national media outlets. Uptick Newswire utilized several metrics while narrowing down the final nominations for the Uppie Awards and selecting the winners. Factors such as how each company presented itself to the market in 2017 were considered, in addition to recent press release news. Detailed up-to-date financials, good standing on the OTC Markets, and company transparency also were taken into account. Other determining factors for choosing the winners in each category were company management, accessibility, and revenue growth. For more information please visit: https://upticknewswire.com/

About EndexxEndexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 — the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “End of Sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense™ is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites include: www.cbdunlimited.com, www.endexx.com, www.phytobites.com .

See: www.C3globalbiosciences.com

Continue reading
0 Comments

PotNetwork Holding, Inc. (POTN) Subsidiary Diamond CBD to Exhibit at the 6th Annual Las Vegas MJBizCon Event

PotNetwork Subsidiary Diamond CBD to Exhibit at the 6th Annual Las Vegas MJBizCon Event

PotNetwork Holding, Inc. (OTC Pink: POTN) announced today that the Company’s subsidiary, Diamond CBD, is exhibiting at the 6th Annual MJBizCon event. This trade show attracts not only the largest, but the most-qualified buying audience of any cannabis event in America.

The MJBizCon Expo is home to over 650 vendors, and expects attendees to exceed 14,000. This semi-annual, all-professional event has earned a reputation of being “the event where deals get done.” Recognized as the fastest-growing trade show in the country across all industries in 2016, more product and service providers in the cannabis industry depend on MJBizCon to deliver results than any other trade event in the industry.

PotNetwork Inc., the Company’s other wholly owned subsidiary will be launching its website, PotNetwork.com, and will be actively interviewing key industry players, and posting event highlights from the show.

Since PotNetwork Holding Inc. repurchased PotNetwork.com in June of 2017, plans have been underway to develop the platform into a counter culture, cutting-edge digital magazine. The magazine will publish daily articles and news related to the cannabis industry.

About PotNetwork Holding, Inc.: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries including First Capital Venture Co., the owner of Diamond CBD, Inc.

Continue reading
0 Comments

International Consolidated Companies, Inc. (INCC) engages Buell & Co. to acquire Medical and Recreational Real Estate

INCC engages Buell & Co. to acquire Medical and Recreational Real EstateInternational Consolidated Companies, Inc. (INCC), has engaged, Denver based, Buell & Company to locate “Commercial Medical and Recreational Real Estate” properties.

Buell & Company is a full service commercial real estate organization specializing in brokerage, development and management.  The company distinguishes itself by working together as a team. Through the active participation of our entire company, we best serve our clients needs.

Founded as T.H. Buell & Company in 1923 by Temple Hoyne Buell, and later renamed Buell & Company, the organization initially established itself as one of the largest and most prolific architectural firms in the Rocky Mountain region.

Buell & Company is committed to providing clients the highest levels of personal and customized service in the commercial real estate industry. http://www.buellco.com

“We are very excited to work with Buell & Co.   It is always great to work with the best of the best in any space.  Roche Fore, Buell principal, is one of the top people in the commercial space nationally.  We feel that this relationship should create significant shareholder value,” said Antonio Uccello, CEO, BluDog Products LLC.

The problem: Banks are calling loans. While, it is lawful under the laws of 30 states to grow and distribute medical marijuana, it is illegal under federal law. Banks, which are mostly federally regulated, are sending letters to landlords requiring them to either remove their marijuana business tenant or have their note called forcing them to refinance or pay off the note.

Continue reading
0 Comments

Marijuana Stocks Must Read Articles For Monday November 13, 2017

Is (CRPGF) Ready For Another Rally?CNRP Mining Inc. (CRPGF) has been on our radar over the last few weeks and what a few weeks it has been. Our new Connect The Dots feature has not only hit new 52-week highs this past week but it has done so on some of the most active days of the market all year! Friday (11-10) (CRPGF) saw consolidation, which wasn’t necessarily a surprise as (CRPGF) has jumped more than 400% over the last few weeks. But after what many saw during Friday’s late afternoon session with that power hour rebound, could there be a signal for another rally in the making?

Click Here for Details

Strong Q3 Growth Puts This Marijuana Stock On Investors’ Radars Key factors driving the continued growth of the marijuana/cannabis market include innovative CBD product introductions, premium pricing due to high-energy consumption in marijuana production, rising social acceptance of marijuana, and a large base of potential cannabis consumers! And one company could be on pace to continue breaking records, EVERY QUARTER of this year!

Click Here for Full Article

Is Illinois Next To Legalize Marijuana?The state of Illinois currently has a medical marijuana program in place and it has decriminalized marijuana, what’s next for the state? A suggested primary ballot referendum to suggest that there is a real possibility that it will be the next state to legalize recreational marijuana.

Continue reading
0 Comments

Player’s Network, Inc. (PNTV) Announces Strategic Partnership with Mobovivo

Marijuana Accelerator, a Division of Player’s Network, Inc., Announces Strategic Partnership with Mobovivo, a Subsidiary of ePlay Digital Inc.Player’s Network, Inc.(OTCQB:PNTV), a publicly traded diversified holding company operating in media and marijuana, announced today a partnership with Mobvivo, a subsidiary of ePlay Digital Inc.(CSE: EPY) to power web and mobile apps for PNTV, Marijuana Accelerator and its clients.

Marijuana Accelerator is currently working on unique, scalable projects which utilize technology to better serve the marijuana industry. Through this partnership, Marijuana Accelerator will  apply the technology, team and expertise of Mobovivo to deliver innovative technology solutions for the marketplace.

The companies have already selected the first new project to accelerate and are finalizing the development agreement. This project is currently in stealth mode and will launch as new travel app with community building features in the coming months. The companies anticipate over $1 million in further projects and developments over the next 2 years.

Mobovivo’s team of engineers are expert developers who enable users and brands to create dynamic, context, interactive, and location-aware experiences including mobile games, customized advertising, and apps (mobile and web).  The project will include the use of a cryptocurrency.

“Marijuana Accelerator is focusing on companies in marijuana media and marijuana tech so there is a lot of need for development,” says Brett H. Pojunis, member of PNTV’s Board of Directors and Co-Managing Director of Marijuana Accelerator. Pojunis continued “we have some remarkable projects we are working on and having the confidence in your development partner makes it easier for us to stay focused on our core competencies.”

“We are thrilled to bring Mobovivo’s team, experience and technology to the PNTV family. The opportunities are simply enormous,” says Jeff Robinson, Co-Managing Director of Marijuana Accelerator.

Continue reading
0 Comments

Best International Marijuana Stock

Marijuana is becoming a global superstar in terms of medical and recreational legalization, and marijuana company’s stocks are following suit. Long gone are the days where a marijuana stock is a small company with only ties to one country.

Canopy Growth Corporation (TWMJF) is in the limelight of the market these days for many reasons, but the focus of this article will remain on its international ventures. The list of countries where Canopy Growth has marked its presence or is in the process of establishing business is noteworthy.

Number one on their list is Germany, as the country recently legalized the use of medical marijuana but must import it while regulations are being drawn for domestic production. Canopy Growth’s Tweed division was the first Northern American company that gained approval to export medical marijuana to Germany last year. Later, the company acquired MedCann GmbH Pharma and Nutraceuticals, a German distributor of medical marijuana.

In 2016, Canopy launched a joint venture with Entourage Phytolab S.A. to market medical marijuana in Brazil and earlier this year established Spectrum Chile SpA to expand their business into Chile.. In September, Canopy announced a supply license agreement with Alcaliber, S.A, who is licensed to grow and market marijuana for medical and scientific purposes in Spain.

Shortly after, the company announced another deal entering the Denmark market with Danish Cannabis ApS, where medical marijuana will be legalized in January 2018. Another deal was made with AusCann Group Holdings Ltd. to supply medical marijuana to the Australian market and they also purchased a minority stake in AusCann. Lastly, there is Jamacia. Canopy is collaborating with Jamaican partners to form Tweed Limited JA to supply medical marijuana to the island.

Continue reading
0 Comments

Defense Bill Allowing Use of Medical Marijuana To Soldiers In Combat?

A new defense bill has surfaced proposing that active duty soldiers are permitted to use experimental medications, including medical marijuana. Let me rephrase that, soon soldiers may be allowed to use medical marijuana while in combat. The goal of the bill is “to reduce the number of deaths or the severity of harm to members of the armed forces… caused by a risk or agent of war,” as stated in a report.

The bill, introduced in the Conference Report HR 2810, would give the secretary of defense the authority to permit military service members that are stationed outside of the United States the freedom to use medications that have not been approved U.S. Food and Drug Administration (FDA). There is immense pressure on Washington not to break policy and leave the responsibly of what is “safe and effective” medicine to the FDA.

There is a part of the policy which allows the FDA to provide the Pentagon with approval for the utilization of experimental medications in the event of a nuclear attack or other kinds of chemical threats. Therefore, the Department of Defense has asked Congress to broaden the existing permission to give the military total control to declare “emergency uses for medical products to reduce deaths and severity of injuries caused by agents of war.” It is believed that granting less restrictive access to medications to the sick or injured service members can increase the number that return home safely,

“Traditional pathways to [FDA] approval and licensure of critical medical products for battlefield use are too slow to allow for rapid insertion and use of these products on the battlefield,” according to the conference report. “This provision could lead to even higher survival rates from severe battlefield wounds suffered by service members.”

Although the bill does not affect life in the United states, it is still opposed by the FDA Commissioner Scott Gottlieb. Gottlieb thinks that military personnel will be at a greater risk without the FDA’s guidance. The FDA has responded to the DOD’s proposal requesting military officials to petition the FDA for emergency medications, which was unapproved.

Continue reading
0 Comments

Is Illinois Next To Legalize Marijuana?

The state of Illinois currently has a medical marijuana program in place and it has decriminalized marijuana, what’s next for the state? A suggested primary ballot referendum to suggest that there is a real possibility that it will be the next state to legalize recreational marijuana.

This March, the voters of Cook County will see a vote on their primary election ballots. Cook County’s Commissioners John Fritchey and Luis Arroyo have conveyed their desire in legalizing recreational marijuana not only in Cook County, but throughout the entire state. Commissioner Fritchey said that legalization would generate a projected $500 million for the state of Illinois in tax revenue.

That’s a nice amount to consider for state programs to improve the lives of the Illinois residents. Nevada reported that the first month of recreational sales generated roughly $3.7 million in tax revenue and other states like Colorado and Oregon have reported solid tax revenues from it as well. Although, revenue is not the only reasoning the state is considering recreational legalization.

Last year, lawmakers decriminalized possession of marijuana under 10 grams. If it was discovered you were in possession under the allotted amount, you are only subject to paying a fine between $100 to $200 at the time of the arrest. The issue with this is, while marijuana is decriminalized one would still have an arrest for drug possession on record. This offense negatively impacts career prospects and even obtaining a loan.

In the next week, Commissioners John Fritchey and Luis Arroyo will recommend the referendum to the Cook County Board. If the Board approves their recommendation, the marijuana vote will be seen on the primary ballot this March.

Continue reading
0 Comments

GW Pharmaceuticals Defeated By The New Largest Marijuana Stock

GW Pharmaceuticals (GWPH) has held the title of champion of marijuana stocks with a market capitalization of nearly $3 billion for the past three years.

GW Pharma’s success is linked to its cannabinoid (CBD) based drug developments. Specifically, the development of Epidiolex, a CBD-based oral medicine has been crafted for the treatment of Dravet syndrome and Lennox-Gastaut syndrome, two rare types of childhood epilepsy. Since marijuana remains illegal throughout the U.S., GW Pharma’s approach to cannabinoid research has kept it ahead of the game, until this week.

Canopy Growth Corp. (TWMJF). took the title on November 8th, with their closing market cap of $2.96 billion versus GW Pharma’s market cap of $2.82 billion.

Canopy Growth is a Canadian-based medical marijuana grower. The company has many factors that have contributed to its success of becoming the largest marijuana stock. Just last month, the company announced that Constellation Brands (STZ) has forked over C$245 million for a 9.9% venture into the company to produce marijuana infused beverages. Canopy Growth is profitable solely from its medical marijuana distribution. It has access to half of the medical marijuana patients in the country due to its acquisition of Mettrum Health earlier this year.

Canada is on track to be the second country in the world to legalize adult recreational marijuana which could double the market. In April, Prime Minister Justin Trudeau introduced legislation with the goal of legalizing recreational marijuana by July 2018. Trudeau has warned that the one way to gain consumers in the legal market is to be competitive on price which leads to the proposed tax rate. The proposed rate is lower than alcohol’s tax, allowing legal marijuana to be price competitive with the black market. This would add billions to the Canopy’s annual revenue.

Continue reading
0 Comments

Strong Q3 Growth Puts This Marijuana Stock On Investors’ Radars

Key factors driving the continued growth of the marijuana/cannabis market include innovative CBD product introductions, premium pricing due to high-energy consumption in marijuana production, rising social acceptance of marijuana, and a large base of potential cannabis consumers.

It also helps that there is a growing trend in popular support for cannabis and marijuana stocks in general. In fact, Research and Markets analysts forecast the global CBD oil sector to grow at a CAGR of nearly 40% during the period from 2017 to 2021. So it would stand to reason that this subsector of the marijuana industry is something to pay attention to right now.

Companies like PotNetwork Holding, Inc. (POTN) are starting to attract the attention of investors through its wholly owned subsidiary Diamond CBD, Inc.. Just this month the company reported its third quarter revenues.

Read Next: PotNetwork Holdings (POTN) Continues To Experience Record-Breaking Growth!

For any company, earnings season is vital to dictating the pace of the months to come and with over $4.4 million for the third quarter, Potnetwork has actually surpassed its Q2 by almost 30%. Even the second quarter figures of over $3 million were impressive as they ripped higher than the first quarter.

Continue reading
0 Comments

mCig, Inc. (MCIG) Takes Further Steps To Capitalize On The Lucrative Cannabis Opportunity In California City

MCIG Takes Further Steps To Capitalize On The Lucrative Cannabis Opportunity In California CitymCig, Inc. ( OTCQB : MCIG ), a diversified company servicing the legal cannabis markets, announced today that the company has applied for a license for manufacturing medical cannabis in California City. MCIG currently has over 2 acres of land in escrow.

MCIG is seeking a license for the manufacturing medical cannabis, which according to the California Department of Public Health, California Code of Regulations Title 17 would allow mCig to do the following:

Produce, prepare, propagate, or compound cannabis products.Extract and infuse process, including processing, preparing, holding, storing, packaging, or labeling cannabis productsPackage or repackage manufactured medical cannabis or medical cannabis products.Label or relabel packages of manufactured medical cannabis or medical cannabis products.Process, prepare, hold, or store cannabis components and ingredients.

“Our team, led by Christina Hernandez, did a fantastic job in managing hundreds of pages of documents and aggressive timelines for this submission. These applications require coordination between legal, engineers, architects, and local government in order to assemble the necessary components within the applications framework and requirements. California City is an independent city with its own mayor, municipal code and city council and as such has the right to govern themselves without interference from the county. Our talented team gives the company very good chances for getting us approved,” explains Paul Rosenberg, CEO of mCig, Inc.

For more information visit our websites:For more information about mCig visit: www.mciggroup.comFor more information about Grow Contractors visit: www.growcontractors.comFor more information about the Cannabis Advertising Network visit: www.eHesive.comFor more information about Blockchain / Cryptocurrency visit: www.renderpayment.comFor more information about Cannabiz Supply in Nevada visit:  www.cannabizsupply.comMore information about Cannabiz Packaging and Supply in California:www.cannabiz.supplyDownload 420Cloud on iTunes or Google Play and make a connection at: www.420cloud.comFor the latest jobs in the cannabis industry visit 420Jobsearch at: www.420jobsearch.comFor the marijuana recipes and cooking tips visit: www.mj.recipesFor more information about Marketaro visit: www.marketaro.comFor more information about VitaCIG visit: www.vitaciggroup.comFor more information about VitaCBD visit: www.vitacbd.comFor the latest cannabis news visit: www.weedistry.comFollow us on Instagram @ https://www.instagram.com/mciginc/Visit us on Facebook @ https://www.facebook.com/mCigInc/Follow us on Twitter @ https://twitter.com/mcigInc

About MCIG Group ( OTCQB : MCIG )

Headquartered in Henderson, Nevada, mCig, Inc. ( OTCQB : MCIG ) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. is committed to being the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry. mCig, Inc. has transitioned from a vaporizer manufacturer to industry leading large scale, full service cannabis cultivation construction company with its Grow Contractors division currently operating in the rapidly expanding Nevada market.

Continue reading
0 Comments

Tauriga Sciences, Inc. (TAUG) Enters into Confidential Settlement Agreement

Tauriga Sciences, Inc. Enters into Confidential Settlement Agreement and General Releases in Connection with the Action Against its Former AuditorsOn November 09, 2017 (the “Effective Date”), Tauriga Sciences, Inc. ( OTC PINK : TAUG ) (“Tauriga” or the “Company”) entered into a Confidential Settlement Agreement and General Releases (the “Settlement Agreement”) in connection with the action against its former auditors pending in the United States District Court for the District of New Jersey, Civil Action No. 3:16-cv-06285 (the “Action”) to resolve all claims between the parties in the Action for a cash consideration of $2,050,000. In addition, as part of the Settlement Agreement, Defendants agreed to release any and all claims against the Company. Upon receipt of the Settlement Payment, Tauriga will dismiss the Action with prejudice. The settlement amount is being funded in its entirety by professional liability insurance for the Defendants.

Tauriga and the defendants agreed to exchange general releases of all claims against the other as part of the Settlement Agreement, including any potential derivative actions, and to avoid any future public comments on the Action, unless required by law.

The Board of Directors of the Company believes it is in the best interest of the Company’s stockholders to enter into the Settlement Agreement to avoid the continuing costs, inconvenience and significant uncertainty of litigation and any potential appeals, delay and further costs that might follow, and allow the Company to move forward with its business plan.

ABOUT TAURIGA SCIENCES, INC.

Tauriga Sciences, Inc. ( OTC PINK : TAUG ) is engaged in building life sciences company through the development, marketing, distribution and potential licensing of a broad array of products and technologies. The Company is presently focused on its upcoming contemplated launch of a Cupacu Butter based lip balm product branded under the name: Herman. The Company has previously disclosed that it plans to launch this product to the retail marketplace during mid-late Autumn of 2017. The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. Please visit the Corporate Website at www.tauriga.com

NON SOLICITATION:

Continue reading
0 Comments

Marijuana Stocks Top Articles – Friday November 10, 2017

(CRPGF) Has Been A Must See; New Highs Coming?CNRP Mining Inc. (CRPGF) is our new Connect The Dots feature. Big news and breaking developments have helped to bring even more attention to this company over the last month or so. (CRPGF) has changed up its focus and is working toward getting involved in the cannabis arena through a deal that gives them rights to XSprays, which holds a proprietary CBD infused product line. Not only has it hit new 52-week highs during every session over the last 4 trading days but after what we saw yesterday (11-9) during the late afternoon session, it could just be the beginning!

Click Here for Details!

DEA Plans To Grow Almost 1,000 Pounds Of CannabisNext year, the Drug Enforcement Agency intends to grow nearly 1,000 pounds of weed, for what though? Good old research.

Click Here for Full Announcement

Medical Marijuana is Legal in Poland Poland became the newest country of the European Union country to legalize marijuana for medical use on July 20, 2017. Last week, Poland’s medical marijuana program commenced just about three months after President Andrjez signed the bill into law. Yet, patients may find the country in shortage as there is no domestic grow program in place.

Continue reading
0 Comments

3 Canadian Marijuana Stocks Moving Off Momentum

Yesterday was an unstable day for Canadian marijuana stocks. This fall came about during a rally as multiple licensed medical marijuana producers trade at overbought levels. For those unfamiliar with the meaning of an overbought stock, here is a little insight. Overbought refers to a situation in which the demand excessively drives the price to levels that are not validated by fundamentals.

Here are three Canadian licensed medical marijuana producers whose stocks are trading at overbought levels and should be watched closely.

Canopy Growth Corp. (WEED.TO) (TWMJF)

Canopy is Canada’s largest and most diverse licensed medical marijuana producer. Last month, Canopy Growth announced that Constellation Brands (STZ) invested $245 million (CAD) for a 9.9% stake in the company to produce marijuana infused beverages. Canopy also solidified the Jamaican medical marijuana market increasing its international expansion as it already exports to Germany, Australia, Spain, Chile, Spain, and Denmark.

Shares of Canopy have been trading at overbought levels with marijuana stock has rallied over 55% over the last month.

Continue reading
0 Comments

DEA Plans To Grow Almost 1,000 Pounds Of Cannabis

Next year, the Drug Enforcement Agency intends to grow nearly 1,000 pounds of weed, for what though? Good old research.

The precise amount that the DEA anticipates from researchers is 443,680 grams of marijuana which is slightly over 978 pounds as well permitting 384,460 grams of THC to be produced for scientific research for next year. The DEA has a few more items their annual list. Quotas need to be met for 92,120 grams of cocaine, 40 grams of LSD, 45 grams of heroin, 30 grams of psilocybin, 25 grams of DMT and the list goes on.

Although 978 pounds of marijuana seems immense, it is less than what was requested in 2016 which was 1,040 pounds. The reduced amount could be associated with Attorney General Jeff Sessions requests limiting the number of new medical marijuana suppliers in a statement. “I think it would be healthy to have some more competition in the supply, but I’m sure we don’t need 26 new suppliers,” said by Sessions.

Justice Department officials have gotten in the way of the DEA from processing the new applications for marijuana suppliers. Regardless of Session’s statement that he’s in favor of some healthy competition, the Attorney General has neglected to answer a bipartisan letter requesting him to remove the block on applications. Because of this, there is only one legal supplier for government weed.

The DEA will grow their marijuana at the University of Mississippi as the university has been the only supplier for government marijuana since 1968. The problem with UM’s marijuana is it does not even compare to what people are smoking. By increasing the suppliers, it would provide more precise research as the United States is years behind regarding marijuana research.

Continue reading
0 Comments

Marijuana Stocks Connect The Dots Feature Hits 52 Week High (Again)

It was only a few weeks ago when we picked coverage back up on a company that we originally introduced during the summer and this time it was debuted as our Connect The Dots feature for the 4th Quarter.

CNRP Mining (CRPGF) has changed up its focus and is working toward getting involved in the cannabis arena through a deal that gives them rights to XSprays, which holds a proprietary CBD infused product line.

We’ve seen momentum build in the market over the last few weeks and we’ve also seen, first hand, the continued developments of this company. Earlier this week, (CRPGF) announced that X-SPRAYS™ has launched a test market for two of its products with a group of Denver, Colorado based medical and recreational marijuana dispensaries.

CNRP Mining Inc. (CRPGF) Target X-SPRAYS Announces Start of Test Market for Products with Colorado Based Dispensary Group

This even has sparked even more intrigue into this company and as a result of heavier bullish momentum, (CRPGF) hit new 52-week highs on Thursday morning!

Since we first released this as our new Connect the Dots feature, (CRPGF) has managed to run 417%! But the best may still be yet to come as many saw this afternoon:

Continue reading
0 Comments

Marijuana Stocks Top Stories For Thursday November 9, 2017

CNRP Mining (CRPGF) Is Our New Connect The Dots Feature & Just Hit New All-Time Highs!

CNRP Mining Inc. announced Wednesday that X-SPRAYS™ has launched a test market for two of its products with a group of Denver, Colorado based medical and recreational marijuana dispensaries. The test market is expected to last three months, after which the Company will provide an update on the sales and performance of the products. And once again we saw how much attention started to build around this company! If you haven’t read our full report, you can access it via the link below.

Click Here for Full Report!

PotNetwork Holding, Inc. (POTN) Announces Distribution Partnership for Easy Grinder™

PotNetwork Holding, Inc. (OTC Pink: POTN) announced today that it has entered into a distribution partnership with Total Vapor, Inc., a subsidiary of Vapor Group, Inc. (OTC Pink: VPOR) to distribute Vapor’s revolutionary, electronic herbal grinder, Easy Grinder™, designed to meet the needs of the Medical Marijuana marketplace. The Company will sell Easy Grinder™ directly to consumers via the website of its subsidiary, Diamond CBD, Inc., as well as distribute it via its extensive reseller network.

Continue reading
0 Comments

Lexaria Bioscience Corp. (LXRP) Files Innovative New Patent Application

Lexaria Bioscience Files Innovative New Patent ApplicationLexaria Bioscience Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has filed a new patent application with the US Patent and Trademark Office (“USPTO”) utilizing the Lexaria DehydraTECHTM technology for delivery of phosphodiesterase type 5 (PDE5) inhibitors – trade names of existing well-known products include ViagraTM (sildenafil) and CialisTM  (tadalafil).

In its new patent application, Lexaria has named the PDE5 inhibitors from the group consisting of avanafil, lodenafil, mirodenafil, sildenafil (or analogs thereof, for example, acetildenafil, hydroxyacetildenafil, or dimethyl­sildenafil), tadalafil, vardenafil, udenafil, acetildenafil, and thiome­thisosildenafil. In addition, under the new patent application each of these named molecules may be combined with a cannabinoid such as cannabidiol (“CBD”), where the cannabinoid delivered in concert may provide complementary vasodilatory activity beneficial together with the PDE5 inhibitor.

A common complaint of existing PDE5 delivery is the slow-acting nature of the substances. Building on existing successful research with cannabinoid delivery, Lexaria believes its patented DehydraTECHTM technology will allow for faster acting treatments in many cases utilizing lower dosage quantities.

As is true with Lexaria’s other patents and patent applications, the new PDE5 patent application is for the improved and more rapid delivery of the named molecules and is meant to be complementary to existing or newly planned consumer products with a view to attracting prospective licensees or partners interested in utilizing Lexaria’s technology in next generation commercial products.

Lexaria’s patented DehydraTECH™ technology is focused on improved delivery methodologies of many commonly used API substances. As such, it provides an additional layer of effectiveness that is designed to harmonize with the intellectual property of third parties. Both patented and generic API substances can utilize Lexaria’s patented technology. Lexaria’s long term strategy is to partner with the world’s leading firms as they deliver best-of-class products to their existing large consumer groups.

Separately, Lexaria announces that a number of existing stock options and warrants have been exercised and Lexaria has received $69,736.50 from their exercise. A total of 364,250 warrants were exercised at prices of $0.14, $0.42, and $0.60; and 55,000 options were exercised at the price of $0.2273; for a total of 419,250 common shares being issued.  The warrants and options are being exercised by third parties who are neither an officer nor director of the Company. All amounts reported in US$. The Company has also issued 875 new 2-year broker warrants with an exercise price of US$0.60.

Continue reading
0 Comments

Future Farm Technologies Inc. (FFRMF) Continues to Build Augmented Reality Cannabis Platform

Future Farm Continues to Build Augmented Reality Cannabis PlatformFuture Farm Technologies Inc. (the “Company” or “Future Farm”) ( CSE : FFT ) ( OTCQB : FFRMF ) is pleased to announce that it has engaged the services of Anthony Flores as marketing and brand manager to help build its Augmented Reality (“AR”) platform brand. As previously announced, Future Farm has acquired the exclusive right to use AR E1, LLC’s (“ARE1″) patented AR technology within the cannabis industry. Future Farm and ARE1 will work together to merge AR and ad-tech with the cannabis industry through the CannaCube Live™ platform.

See Augmented Reality Video Here: Augmented Reality Cube

An overview of the business model is available for download on Future Farm’s website or by using the following link: Augmented Reality Presentation

Flores’ ten years of experience in strategic marketing, coupled with his four years of Augmented Reality marketing, brings a unique strength to this pivotal marketing role. His wide portfolio includes strategic marketing to creative direction of innovative experiential programs Swarovski, Pepsi, Mercedes Benz, and Zound Industries. In addition to his agency experience, Flores brings a strong background in lifestyle positioning serving the cannabis industry, having worked on strategic marketing and retail positioning campaigns for PAX and Golden State Sciences.

Flores will play a key role in the strategic marketing of the Augmented Reality CannaCube Live™ platform advancing its portfolio of Augmented Reality marketing capabilities to dispensaries, cultivation and extraction facilities and other marijuana businesses.

“I am tremendously impressed with this leadership team, its progressive model and its ability to realize the vision of a modern cannabis industry that leverages Augmented Reality,” says Flores.

Continue reading
0 Comments

This Marijuana Stock Adds $806 Million to Market Value

The Canadian marijuana market is booming now more than ever. Canopy Growth’s (TWJMF) shares have rose by 54%, adding $806 million in market value in just five weeks. Canopy is the first marijuana producer to reach the mid-cap zone with a valuation over $2 billion and it is the largest marijuana stock in terms of market capitalization. With sales over 100% per year Canopy Growth (TWJMF) is a growing favorite among investors. What’s the reasoning behind the company’s recent success?

Last month, a historic deal in the marijuana industry was made. The S&P 500 company, Constellation Brands (STZ) announced its $190 million investment into Canopy for small 9.9% stake. The Corona maker and the marijuana grower came together to market and sell marijuana infused beverages, as Constellation believes investing in marijuana was pertinent to staying ahead of market dynamics. With Constellation showing undoubted confidence in the marijuana industry, it opens the flood gates for other major companies to ride the marijuana wave.

The Prime Minister of Canada, Justin Trudeau, announced legislation back in April to permit the use of recreational marijuana for adults. The country is set to become second in the world to legalize recreational marijuana by July 2018. Canopy possess the highest market share for the country’s medical marijuana market, so one would assume that it would as well for the highly anticipated recreational market. Canopy is also one few growers who’s permitted to export dried marijuana overseas to countries that have legalized medical marijuana without domestic growing capabilities.

The tax proposal announced in October, suggested a tax of $1 Canadian for marijuana priced up to $10 a gram and a flat tax of 10% on marijuana above that. This is more favorable than alcohol’s tax in the country. Trudeau believes that the only way to eliminate black market is to be competitive in pricing. Low tax rates will provide legal growers such as Canopy the chance to supply the high demand once legalization commences. To meet anticipated demands, Canopy has been acquiring increased acreage as well developed companies.

The post This Marijuana Stock Adds $806 Million to Market Value appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

Reliq Health Technologies Inc. (RQHTF) Announces Receipt of Second Milestone Payment from NextGen, and Upcoming Investor Call

Reliq Health Announces Receipt of Second Milestone Payment from NextGen, and Upcoming Investor CallReliq Health Technologies Inc. (RHT.V) (RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative remote patient monitoring, care coordination and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has received the second milestone payment from NextGen Applications LLC of San Antonio, TX (“NextGen” – NextGenApplicationsLLC.com, ) per the contract between Reliq and NextGen.  The contract, whose total value is $1.22 Million USD, provides NextGen with professional services and a limited license to Reliq’s proprietary iUGO Care platform, specifically for the development of a consumer focused mobile health app (“mTelecare App”), providing service to the greater San Antonio area before expanding elsewhere throughout the U.S.

“We are pleased to have achieved the second milestone in this contract on schedule,” said Dr. Lisa Crossley, CEO of Reliq Health. “NextGen’s initiative to improve health outcomes and enhance access to care through the mTelecare App is directly aligned with Reliq’s focus on Community-Based Healthcare.  Working in conjunction with NextGen Applications, we will be able to leverage our existing platform to create a customized mobile health app that will allow the residents of San Antonio and elsewhere to proactively manage their own health.”

“NextGen’s partnership with Reliq Health will allow us to utilize their existing mHealth platform to provide a novel, innovative mobile healthcare solution to the citizens of San Antonio and surrounding area,” said a spokesperson of NextGen Applications.  “The resulting mTelecare mobile app will provide a telemedicine platform that connects patients to doctors and nurses anywhere where there is internet access.  mTelecare will support secure video consults for patients with doctors and nurses, providing patients with professional care from the comfort of their own home.  The mTelecare app will also provide automated prescription refills, search tools for healthcare services, a personalized health calendar with push notifications, reminders and a suite of billing and payment tools.  mTelecare will provide greater access to healthcare, while at the same time reducing healthcare costs.”

The City of San Antonio, Texas is the seventh most populated city in the United States and the second most populated city in Texas, with a population of over 1.4 Million residents.

The Company is also pleased to announce that it will be hosting a investor call on December 1, 2017 at 8:00am PST/11:00am EST.  Please visit the Company’s website (www.reliqhealth.com) the week of November 20, 2017 for call in details and information on how to submit your questions electronically in advance of the call.

ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and Director

Continue reading
0 Comments

PotNetwork Holding, Inc. (POTN) Announces Distribution Partnership for Easy Grinder™

PotNetwork Holding, Inc. Announces Distribution Partnership for Easy Grinder™

PotNetwork Holding, Inc. (OTC Pink: POTN) announced today that it has entered into a distribution partnership with Total Vapor, Inc., a subsidiary of Vapor Group, Inc. (OTC Pink: VPOR) to distribute Vapor’s revolutionary, electronic herbal grinder, Easy Grinder™, designed to meet the needs of the Medical Marijuana marketplace. The Company will sell Easy Grinder™ directly to consumers via the website of its subsidiary, Diamond CBD, Inc., as well as distribute it via its extensive reseller network.

Maria Gomez, Regional Vice President of Sales for Diamond CBD, Inc., stated, “We are constantly on the look out for new, superior, cutting-edge products to add to our consumer offerings and distribution to our resellers. Easy Grinder™ is such a product as it is unmatched in performance and consumer features.” She added, “We are excited to add Easy Grinder™ to our product line as we continue to expand our offerings into new areas to better serve the wants and needs of our many customers.”

Dr. Richard Goulding, CEO of PotNetwork Holding, Inc., explained further, “Consistency is imperative in the medical field. As most people don’t have sensitive enough scales to quantify specific dosages, Easy Grinder™ offers the consumer reproducible volume control of the product. Hemp-derived CBD oil contains no THC. And there are certain disease entities that require the THC component to be effective. Notably, PTSD, post-traumatic stress disorder, is well controlled in many instances with marijuana. The THC interferes with the triggering mechanism of an event, disrupting the associative pathway generating PTSD symptoms. It’s why active marijuana is needed and why more and more states are embracing the pure marijuana product for medicinal purposes. But in order to effectively dose the patient, the Easy Grinder™, will prove imperative.” He added, “Easy Grinder™ in addition to our CBD product line is another example of how we are expanding the focus of the Company to meet the health needs of our multifaceted customer base.”

About Vapor Group, Inc.: Vapor Group is focused on the acquisition and development of commercially viable intellectual property and proprietary products. The Company’s subsidiary, Total Vapor, Inc. holds the worldwide distributor of Easy Grinder™ from its developer and manufacturer, EZ Grinder, Inc. Vapor Group also owns Simple Cork, Inc., the developer of a new, multi-nationally patented and patent pending combination wine bottle cork/opener being prepared for market entry in 2018.

PotNetwork recently announced that the Company had retained the auditing services of East West Accounting Services, LLC, a Public Company Accounting Oversight Board (PCAOB) registered CPA firm, to provide a methodical review and analysis for the audited verification of the Company’s recent monthly reported revenues.

Continue reading
0 Comments

Will the DEA Arrest CBD Users?

Although the state of Indiana recently passed legislation legalizing CBD oil for certain patients, state law enforcement continues to pursue those who use and sell CBD products. CBD is a non-intoxicating byproduct of the cannabis plant known as cannabidiol and has shown health benefits for those suffering from numerous health conditions.

Back in June, the Indiana State Excise Police had been on raids throughout Indianapolis because of the federal agency’s opinion that CBD products were still illegal. The outrageous raids created a lot of buzz in the media leading to Governor Holcomb ordering the police to end raids related to CBD products. The states Attorney General Curtis Hill then governed that the possession of CBD oil is no longer a crime and cleared CBD products for retail.

“Commercial products manufactured from industrial hemp are lawful to possess and sell in Indiana,” Curtis wrote to the Indiana State Police. “A short list of these products may include, but are not limited to, hemp rope, hemp hand lotions, CBD oil, hemp shoes and other clothing articles manufactured from industrial hemp. Keep this information in mind in the event you encounter such products in the course of your duties, and remember these products are lawful to purchase and possess.”

As time went on, some of the state law enforcement decided to go against the legislation and continued to arrest those in possession of CBD oil. DEA officials believe that Indiana’s law enforcement is taking CBD way too seriously.

Rusty Payne, a spokesperson for the DEA said all thought CBD is still illegal under the Controlled Substances Act, “he cannot blame parents” for taking the chance to obtain medicine for ill children.

Continue reading
0 Comments

mCig Inc. (MCIG) Expands Construction Project Portfolio and Wins an Exclusive Contract in California, Valued at $5M

mCig Expands Construction Project Portfolio and Wins an Exclusive Contract in California, Valued at $5M mCig Inc. ( OTCQB : MCIG ), a diversified company servicing the legal cannabis, hemp and CBD markets, is pleased to announce that its Grow Contractors division has entered an exclusive agreement to build and develop a 31,000 square foot state of the art cultivation, extraction, and distribution facility located in a prime area of the San Gabriel Valley in California.

“The past few months in California have been absolutely amazing for the entire cannabis industry in SoCal; I’ve never seen this level of activity in other states when they had first become recreational. I can already tell that this is going to be quite the market and we’re perfectly poised to take advantage of it,” says Robert Kressa, CEO of Grow Contractors.

The buildout is valued at over $5M with exclusive rights having been granted to Grow Contractors for the entire construction project. The cultivation area alone will be 22,000 square feet with over 500 flowering lights.

In conjunction, extraction is expected to match cultivation revenues. Cannabis extracts make up a huge portion of the marijuana market accounting for about one third of all marijuana sales. The extraction lab will primarily be equipped for the production of distillate and for the filling of vape pen cartridges. In total, the facility will produce over 100 separate SKU’s. Distribution will also be contained within the facility as a service to facilitate delivery to retailers, with a fleet of vehicles and drivers maintaining a logistics backbone to service the entire Southern California region.

“Our Grow Contractors division was very busy in the last few months, finishing old construction projects, bidding on a new ones, and most importantly, changing its business model. The division took some time to restructure and clean up past projects, including canceling some non-performing operations in order to move forward. We look forward to our expanded presence in California and more to come. Expect many more construction, management, and exclusivity announcements from Grow Contractors,” stated Paul Rosenberg, CEO of mCig Inc.

About Grow Contractors

Continue reading
0 Comments

Tetra Bio-Pharma Inc. (TBPMF) Concludes its First Sale of Rx Princeps(TM) Inhalation Device

Tetra Bio-Pharma Concludes its First Sale of Rx Princeps(TM) Inhalation DeviceTetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced its first sale of its Rx Princeps™ inhalation device. The sale of this inhalation device is the first step towards the sale of Rx Princeps™.

“I am happy to announce the first batch order of our medical cannabis inhalation devices. This is the first step in generating a steady revenue stream and it is the beginning of a new phase in our development. Sales of Rx Princeps ™ inhalation device will be an additional revenue stream for Tetra. Our inhalation device is a unique, high quality, CSA-approved customized titanium pipe, designed by our partner, Ford Pharmacy. With this launch Tetra is providing a high quality, standardized treatment with clinical data to patients in need.” As Rx Princeps™ (dried cannabis) will soon be launched under ACMPR through Aphria, and we are expecting to generate around $1.5 millions in sales, in fiscal 2018. Through our promotion and education efforts in Quebec, New Brunswick and part of Ontario, we estimate that over eight thousand patients will start using Rx Princeps™ under prescription from their doctors over in the next twelve months.” states Bernard Fortier, CEO of Tetra.

Mr Fortier highlights that “It is important to consider that only 4 % of physicians today consider prescribing cannabis. A fixed-dose approach, as we are promoting based on our original clinical data, is attractive to doctors because the treatment dose is standardized. We have a huge opportunity in educating doctors on our clinical approach.”

Tetra has received its first sales order from Sante Cannabis. Sante Cannabis is the first cannabinoid clinic and medical marijuana resource centre in Quebec. Healthcare professionals from Sante Cannabis support patients in their medical journey with cannabis.

Rx Princeps™ allows patients to optimize the benefits of medical cannabis through the intake of a standardized amount of product. The Rx Princeps™ inhalation device is an essential accessory to ensure consistency of treatment, as well as optimize the potency of the product, while minimizing wastes for the patient.

200,000 patients are already registered under the ACMPR program and around 1.5 million adults in Canada suffer from chronic pain and are considered non-responders to opioids; medical cannabis could be a therapeutic answer for those patients but physicians need bioavailability and safety data to prescribe medical cannabis with confidence. According to Health Canada, less than 3,000 physicians actually prescribe cannabis to their patients. Tetra is committed to provide them this data. Tetra has begun educating pain clinics and the medical profession across Canada on Rx Princeps™, including its advantages for patients. The Tetra medical team was at the Academic Pain Day hosted by the Ontario Pain Foundation this Wednesday to inform pain physicians about the benefits of Rx Princeps™. This was also an opportunity to introduce to them Tetra’s phase 1 data on its drug candidate PPP001.

Continue reading
0 Comments

Player’s Network, Inc. (PNTV) Announces the Launch of Phase 2 and Project Grow Tent Event

Green leaf Farms, a Division of Player’s Network, Inc., Announces the Launch of Phase 2 and Project Grow Tent EventPhase 2 is an 8,000 sq. foot expansion of Cultivation for Green Leaf Farms and Project Grow tent a collaboration with Local Artist.

Player’s Network, Inc. (OTCQB:PNTV), a diversified holding company operating in media and marijuana, announced today that Green Leaf Farms Holdings, LLC (Green Leaf) is having its ribbon cutting grand opening of its 8,000 sq. ft expansion on November 16th at 5pm and is inviting a special VIP list that includes, cannabis industry leaders,  all its investors and major shareholders to join in a unique art experience titled Project Grow Tent.

Phase 2 is a major milestone for Green Leaf as this expansion will generate substantial revenues starting in Q1 2018. The concept of painting the tents was developed in response to the requirement set forth by City of North Las Vegas to add a layer of fire retardant paint on our cultivation tents. The result was turning the well designed, nice black canvas finish into a less desireable muddy gray color finish. Green Leaf’s operations manager Jason Ching came up with the idea of adding some color to the tents and identifying local mural and graffiti artist to take on the project. Green Leaf contracted the ISI Group, which is a network of local artist that brought on 4 artist to freestyle paint each tent, in addition with two (2) PNTV team members.

Upon completion of the event Green Leaf will have its final inspection and Certificate of Occupancy approval to expand its cultivation operations into the new wing. Green Leaf currently has over 1,400 clones and small plants consisting of 15 strains that are ready to populate the 6 tents and a large open grow area making up the 8,000 foot expansion. Individual tents allows Green Leaf to create several unique growing areas. The main purpose is to separate plants in vegetation versus plants that are in flowering stages.

In addition to the Art, this opening is the first of its kind offering 12 of Green Leaf sponsors the opportunity to demonstrate their products in a working cultivation center. The opening is taking place concurrently in Las Vegas during the MJBizCon the industry’s biggest show of the year that is attracting more than 14,000 Cannabis business leaders, who are welcome to visit our facility.

Once the new wing is in full perpetual production the growing cycle can begin its first harvest in about 120 days, it is estimated will produce around 125 pounds per month. Currently the average wholesale pound of flower (buds) in Nevada is selling for $2,400 which is expected to vary month to month depending on the market demand.

Continue reading
0 Comments

Marijuana Stocks Must Read News & Articles – November 8, 2017

CNRP Mining (CRPGF) Target X-SPRAYS Announces Start of Test Market for Products with Colorado Based Dispensary Group

CNRP Mining Inc. (CSE:CND) (CRPGF) (the “Company” or “CNRP Mining”), is pleased to announce that X-SPRAYS™ has launched a test market for two of its products with a group of Denver, Colorado based medical and recreational marijuana dispensaries. The test market is expected to last three months, after which the Company will provide an update on the sales and performance of the products. The products that will be subject to the test market are: 300mg CBD and Sleep with CBD.

Click Here for Full Release!

This Marijuana Stock Is Up 255% & Hit New All-Time Highs

Click Here for Full Article

Continue reading
0 Comments

CNRP Mining Inc. (CRPGF) Target X-SPRAYS Announces Start of Test Market for Products with Colorado Based Dispensary Group

CNRP Mining Target X-SPRAYS Announces Start of Test Market for Products with Colorado Based Dispensary Group

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

CNRP Mining Inc. (CSE:CND) (CRPGF) (the “Company” or “CNRP Mining”), is pleased to announce that X-SPRAYS™ has launched a test market for two of its products with a group of Denver, Colorado based medical and recreational marijuana dispensaries. The test market is expected to last three months, after which the Company will provide an update on the sales and performance of the products. The products that will be subject to the test market are: 300mg CBD and Sleep with CBD.

About X-SPRAYS

X-SPRAYS is comprised of dedicated scientists and product engineers who are passionate about health and creating the ultimate delivery system for optimal nutrition. The company has focused its efforts in creating a product line of oral sprays to deliver medicines, nutrients and vitamins. To date, X-SPRAYS has developed a novel line of 8 health care and life enhancement nutraceutical products focused on enhancing pain relief, awareness, sleep, libido, energy and recovery.

The Company’s product line is ready for commercialization with 8 novel sprays that include both hemp cannabidiol (CBD) and nutraceutical ingredients (4 with CBD and 4 nutraceutical). X-SPRAYS intends to expand its product line to include cannabis Tetrahydrocannabinol (THC) and CBD sprays. For more information, please visit the company’s website at: www.x-sprays.com.

Continue reading
0 Comments

Are You Digging These Cheap Marijuana Stocks?

As the marijuana industry continues to grow at a rapid pace, it is no wonder why investors continue to dig deeper into their pockets for marijuana stocks. Taking the 15 largest marijuana stocks, in terms of market caps exceeding $200 million, there are three that are relatively inexpensive.

Scotts Miracle-Gro takes the lead as the most profitable and cheapest marijuana stock, although only around 10% of its sales are linked marijuana. The Hawthorne Gardening division that focuses on hydroponics, lighting, soil, and nutrients for the medical marijuana industry is seeing immediate growth. The company reported a 21% organic growth rate for Hawthorne during the third quarter compared to the previous year.

The company’s Hawthorne Gardening division continues to bring in larger amounts of sales with each passing quarter. Scott’s may be the most secure way for an investor to dabble in the industry. Scotts is forecasted to deliver $3.93 in full-year earnings per share in 2017 and a $4.38 per share in 2018.

MedReleaf is the Canadian medical marijuana producer which went public in May 2017. The company has reinvested its proceeds from its IPO in expanding its growing capacity in anticipation of recreational legalization. With Canada moving towards recreational legalization for 2018, the new market could bring in another $5 billion to $7 billion in annually in sales.

The company’s fiscal fourth-quarter and full-year release revealed it exceeded doubling its sales to $31.4 million in fiscal 2017 and generated $8.5 million in net income. The company has a growth rate of around 100% and is being valued at 94 times its full-year net income.

Continue reading
0 Comments

Medical Marijuana is Legal in Poland

Poland became the newest country of the European Union country to legalize marijuana for medical use on July 20, 2017. Last week, Poland’s medical marijuana program commenced just about three months after President Andrjez signed the bill into law. Yet, patients may find the country in shortage as there is no domestic grow program in place.

Doctor Marek Bachanski is the country’s leading medical marijuana practitioner and a pediatric neurologist who has doubts about the new program. Bachanski stated, “Polish patients will have very limited access to this type of treatment because we don’t produce medical marijuana domestically”.

Since Poland does not domestically grow marijuana, the pharmacies will have to import raw smarijuana process it on site. The new law permits about 90 percent of Poland’s pharmacies to produce marijuana medications, but restricts the growth of plants. Because of this, product will come with higher price tags.

Although, marijuana is currently being imported from the Netherlands, Bachanski believes that imports are already inadequate to handle the demand from prospective patients. MP Piotr Liroy-Marzec, one of the bill’s writers, continues to fight for the change to permit domestic cultivation. This is opposed by Polish lawmakers as hey foresee growing marijuana domestically may lead to unwanted recreational legalization.

Other than the cultivation issue, the law is generous. It eradicates THC restrictions on cannabis oil. Patients now have access CBD or THC dominant cannabis oil. Poland’s medical marijuana law was created with the ill in mind. The law doesn’t list specific conditions and makes legal marijuana treatments accessible those with chronic pain, nausea and vomiting related to cancer treatments, multiple sclerosis, epilepsy and other drug-resistant conditions. The open-ended language of the law was intentional as lawmakers envisioned the expansion of usage for other conditions in the future.

Continue reading
0 Comments

This Marijuana Stock Is Up 255% & Hit New All-Time Highs

(CRPGF), Our Connect The Dots Focus Piece, Continues To Hit New All-Time Highs

When we didn’t think it couldn’t get any better…it just did! Yesterday we said that our newest Connect The Dots featured company (CRPGF) was one of the most exciting features we’ve seen in awhile. True to form, (CRPGF) just keep running! Even this morning when (CRPGF) gapped up to $1.25 at the opening bell, the gap filled and then we saw one epic run from about $1.09 to highs of $1.35! Since we picked back up coverage on this emerging CBD company, it has seen a run of 255%!

(CRPGF) seems to be running on all cylinders and it’s this reason that is showing exactly why we have been so particular about what we put into the category of “Connect The Dots” features. Even with the late consolidation we saw this afternoon, (CRPGF) still closed green, up 17.65% and overall, (CRPGF) finished Tuesday’s session up 215.8% since we reintroduced this as our new Connect The Dots feature!

As many of you know, (CRPGF) has a company name that doesn’t reflect the new direction of its business with XSprays…that’s how “early stage” we think that we are seeing this company

We asked you this question last night: How many times have you had something on your watchlist in the same situation as (CRPGF)? Right now, we’re seeing this company emerge directly from the early beginnings and the market appears to be catching the wave as well! Have you connected the dots, yet?

Continue reading
0 Comments

Marijuana Stocks PreMarket Buzz – November 7, 2017

REMINDER: (CRPGF) Is Our Connect The Dots Focus Piece

We Have Begun Coverage of Our Newest Long Term “Connect The Dots” Piece, (CRPGF)! But don’t let the name fool you – this “ain’t no mining alert”. Several key developments over the last few weeks have shown heads turning toward this company as it breaks into the MJ arena in a big way! Click HERE or Below for the full report!

Click Here for Instant Access!

Has The Canadian Market For Marijuana Stocks Doubled?Canada’s main marijuana producers are patiently waiting for national legalization and what’s in store for their revenue and stock prices. Current marijuana stock valuations suggest great potential with Canopy Growth Corporation as the largest marijuana stock in terms of its market cap of $2 billion and other companies not too far. Numerous endeavors have been completed to calculate the market size once legalization is achieved and one of the most recent attempts has investors attention.

Click Here for Full Update

Continue reading
0 Comments

Green Cures & Botanical Distribution, Inc. (GRCU) will exhibit at the “High Times Harvest Cup”

Green Cures & Botanical Distribution Inc. And Purple Haze Properties will exhibit at the “High Times Harvest Cup”Green Cures & Botanical Distribution, Inc. ( OTC PINK : GRCU ): On November 11th through November 12th in San Bernardino, High Times will be holding their annual Harvest Festival, where hundreds of entrees have been sent in to try to win one of the legendary Cannabis Cups. Purple Haze Properties will be exhibiting and will have their various celebrity licensed cannabis lines for sale for attendees. They will have “Money B” from “Digital Underground” and various members of the Hip Hop group “Tha Alkaholiks” present to support the cannabis products launched by licensees of Purple Haze Properties.

“I am really excited for The Cup and hopefully end the year with an award. We entered our ‘Jimi’s Stardust’ in the Infused Cannabis Category as well as our amazing “Jimi’s Hashteroids” in the non-solvent hash category,” states Andrew Pitsicalis, GRCU spokesperson and CEO of Purple Haze Properties.

Legendary bands like George Clinton and the P-Funkadelics, Naughty by Nature, Bone Thugs & Harmony, and others will be jamming at The Cup this weekend. Purple Haze properties has also paired as a Cannabis Agent for UAA (Universal Attractions Agency), with a massive roster of celebrities that will be going PHP this year. Look forward to a bunch of great celebrity cannabis products to be launched with Green Cures Botanicals. Come join us at the High Times Cannabis Cup and try some of these great celebrity cannabis products from PHP or look forward to enjoying it in California dispensaries state wide.

Our Hollywood Hemp product line will be available for sale at our booth as well. Be sure to stop by and partake of our bounty of wonderfully engineered products.

We are excited to also announce the final transitions next week inducting, the new President of GRCU and the appointment of a new advisory board. We are really excited for the new direction of the company and look forward to getting products out in dispensaries in California and bringing in new revenue for the investors and company alike.

Purple Haze Properties, LLC was founded through a partnership between Andrew Pitsicalis and Leon Hendrix, blood brother to the legendary guitar icon Jimi Hendrix. Purple Haze Properties, LLC is the premier source for Jimi Hendrix cannabis related products as well as a premiere celebrity licensing company for the Cannabis Industry. We represent Cannabis Licensing for many celebrities including Jimi Hendrix, Digital Underground, Janes Addiction, Money B, The Emperor of Hemp, Jack Herer and others. Purple Haze Properties participates in all aspects of the cannabis industry including Licensing, Social Media, Medicinal, Music and Entertainment areas. Check us out at

Continue reading
0 Comments

Who Decides The Fate Of CBD?

This month, a World Health Organization conference will be held in Geneva, and could influence the policies around the world regarding the regulation of cannabidiol (CBD).

The meeting of the Expert Committee on Drug Dependence (ECDD) will take place from November 6 to 10 for the assessment of certain psychoactive substances including CBD. This is an annual process for the reviewal of psychoactive substances in terms of regards to health, abuse, and dependence. From here the ECDD makes recommendations regarding regulations of the drug to the United Nations Secretary-General.

Chosen to speak about CBD at the conference is Raúl Elizalde, president of HempMeds Mexico. Elizalde was influential to the legalization of medical marijuana in Mexico as he has been an advocate ever since using CBD during the treatment process of his ten-year-old daughter’s epilepsy. HempMeds is the only company permitted to produce medicinal marijuana by the Mexican government.

Elizalde is against the regulation of CBD, stating, “I’m excited to speak with global leaders and urge them to not consider CBD psychoactive and not schedule it as a drug”. He believes that regulation will limit CBD’s use in the pharmaceutical industry and it should be classified as a dietary supplement.

“I hope [they] will consider CBD to be similar to vitamin C, a supplement that has a recommended daily dose—not a drug that then needs to be scheduled,” Elizalde added.The decisions of the ECDD may bring on broad effects. The Convention on Psychotropic Substances is a UN treaty that details which substances should be regulated by member nations, which includes the United States. If the United Nations determines CBD is not subject to regulation this may start the process of reclassification under the Controlled Substances Act as CBD is currently listed as a Schedule 1 narcotic.

Continue reading
0 Comments

Has The Canadian Market For Marijuana Stocks Doubled?

Canada’s main marijuana producers are patiently waiting for national legalization and what’s in store for their revenue and stock prices. Current marijuana stock valuations suggest great potential with Canopy Growth Corporation as the largest marijuana stock in terms of its market cap of $2 billion and other companies not too far. Numerous endeavors have been completed to calculate the market size once legalization is achieved and one of the most recent attempts has investors attention.

Canada’s Parliamentary Budget Officer (PBO) is responsible for estimating the financial costs of proposed legislation. A report released last year by the PBO described financials regarding the legalization of marijuana. The PBO concentrated on valuing consumption and then predicted prices to forecast the market size. The analysis led to the PBO estimating the value of the Canadian marijuana market to be between $4.2 billion and $6.2 billion in 2018.

With Canada moving towards recreational legalization in 2018 the PBO estimates marijuana usage to rise to 734 million metric tons by 2021 from about 635 million metric tons in 2018. With that being said, the marijuana market should be around $7 billion within four years which is consistent with the government’s Task Force on Cannabis Legalization and Regulation estimation of the illegal recreational-marijuana market.

A new estimate of the up and coming marijuana market has emerged and it’s higher than previous estimates. Analyst Colin Firth joined Oraclepoll Research to find the most recent potential of the market. Five thousand Canadians were asked 75 detailed questions about marijuana use. The survey suggested that the number of marijuana users will be closer to 11 million in 2021 rather than the 5.2 million previously reported. This change brings the market closer to a valuation of between $8 billion and $12 billion annually, double what has previously been predicted.

What does this mean for Canadian marijuana stocks? It is possible that the high valuations for the companies in this rapidly growing industry are not farfetched at all.

Continue reading
0 Comments

This Marijuana Stock Is On Fire!

(CRPGF), Our Connect The Dots Focus Piece, Is On Fire!

We Began to pick back up on coverage of Our Newest Long Term “Connect The Dots” Piece, (CRPGF) toward the tail end of October when it was trending right around $0.38. Today, (CRPGF) managed to hit a high of $1.09! This has been a run of 184.7% since we debuted this company as our newest “Connect The Dots” feature….(how you doin’).

Here’s the thing: Because of the early developments of this company, we strongly feel that this is just the beginning for (CRPGF). The LOI, definitive agreement, and capital raises are centered around ONE KEY TOPIC: Bringing the X-Sprays brand into “the fold” of the company’s revenue model. As we said before, we are literally seeing this company emerge from its grass roots.

The simple fact that (CRPGF) continues to hit a stride is showing exactly why we have been so particular about what falls into the category of “Connect The Dots” features. Specifically with (CRPGF), as many of you have seen, the name of the company is not currently reflective of its new direction. We think this shows exactly how early it is that we’re looking at this company!

How many times have you had something on your watchlist in the same situation at (CRPGF)? We’re guessing it isn’t many. But now, in real time, we’re seeing this company emerge right from the early beginnings and the market seems to be catching the wave as well! The only real question left is, “What’s Next for (CRPGF)?”

Continue reading
0 Comments

Marijuana Stocks Monday Market Update – November 6, 2017

(CRPGF) Is Our Connect The Dots Focus Piece

We Have Begun Coverage of Our Newest Long Term “Connect The Dots” Piece, (CRPGF)! But don’t let the name fool you – this “ain’t no mining alert”. Several key developments over the last few weeks have shown heads turning toward this company as it breaks into the MJ arena in a big way! Click HERE or Below for the full report!

Click Here for Instant Access!

Going Green: An Investor’s Guide to Cannabis StocksThe long war on cannabis is finally coming to an end, And Wall Street has kept a keen eye on it. With legalization sweeping over America, lots of investors believe that they are on the brim of jumping right into a new revolutionary industry that is changing society as well as all the other industries that exist within it.

Click Here for Full Update

Continue reading
0 Comments

Novus Acquisition and Development, Corp. (NDEV) Showcased by Cannabis Business Times

Novus Showcased by Cannabis Business TimesNovus Acquisition and Development, Corp. (OTC PINK: NDEV), through its wholly-owned subsidiary, WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident and the nation’s first carrier/aggregator offering a cannabis health plan. NDEV today announced a featured cover article in Cannabis Business Times publication.

Cannabis Business Times (CBT) is a leading cannabis industry publication that focuses accelerated success of the legal cannabis cultivators, manufacturers, dispensaries, and patient advocacy. CBT provides actionable intelligence in all aspects of the industry, from legislation, regulation, and compliance news to analysis of industry trends, as well as expert advice on cultivation, marketing, financial topics, legal issues, and more.

CBT focuses strictly on the business of legal cannabis for medical and recreational use and aims to provide timely information – through its website, e-newsletter, mobile app, print magazine and annual cultivation conference – to help the reader make timely, informed decisions to help them run their businesses better and more profitably.

About Novus

Novus Acquisition & Development Corp. (NDEV), through its subsidiary WCIG Insurance, provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as, health, property & casualty, life, accident and fixed annuities.

Novus medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. Once a push notification is completed the transaction is solely between the state-licensed dispensary and the registered patient.

Continue reading
0 Comments

This Marijuana Stock Was Unaffected By Bad Earnings

Insys Therapeutics was expected by analysts to announce poor results for their third quarter. While the company is trying to convert into a cannabinoid-focused biotech with its cannabinoid drug Syndros, the company reported losses much higher than expected which did not affect this marijuana stock, not even one bit.

Insys had reported for the third quarter a 47% decline in net revenue, $30.7 million, from the previous year and a net loss of $166.3 million, or $2.30 per share.

The launch of Syndros did not meet the company’s expectations to be its saving grace from the Subsys scandal. Sales for Syndros, which treats chemotherapy-induced nausea and vomiting, and anorexia associated with AIDS, was about $700,000 which is nowhere near the anticipated annual $200 million. An amount clearly not enough compensate from the decreased revenue of the company’s previous star candidate Subsys.

While prescription were volumes decreased for Subsys, the company was receiving higher product returns because of this. The company determined that its net revenue was negatively impacted roughly $5 million from product returns. The company’s stock quickly fell and rebounded even faster.

Insys had to set aside $150 million regarding the ongoing Department of Justice (DOJ) investigation into the company’s illegal marketing practices for Subsys. Excluding this, the company’s net loss would be bear $15.5 million or $0.21 per share. That’s still worse than what analysts expected, but it’s much closer than the actual reported net loss for the third quarter.

Continue reading
0 Comments

3 Canadian Marijuana Stocks To Watch In November

The Canadian marijuana stock market has struck more appeal from investors over the last year. Canada’s medical marijuana market is forecasted to be worth $1.1 billion Canadian dollars by 2020 with nation legalization projected for mid-2018 the combined market is estimated to be valued $2.8 billion. Most marijuana stocks are reporting average gains of 100% in the past year; here are a few marijuana stocks that are in the spotlight.

Canopy Growth Corporation (TWMJF) is a marijuana producer and the largest marijuana stock in terms of market cap at nearly $2.18 billion. (TWMJF) announced its game changing $191 million-dollar deal giving the S&P 500 maker of Corona, Constellation Brands, a 9.9 percent stake into TWMJF. The companies are the in the industry to plan and sell marijuana-infused beverages.

“We are thrilled to have the backing of such a well-established and respected organization such as Constellation Brands,” said Bruce Linton Chief Executive Officer of Canopy Growth. Adding, “We look forward to working with the Constellation Brands team to access their deep knowledge and experience in growing brands as we continue to expand our business”.

Prior to the deal, (TWMJF)’s stock closed at $9.99 on October 27th and since has seen major spikes in volume and highs of $13.24 gaining a solid 32.53 percent in just a few days.

Medreleaf Corp. (MEDFF) is first and only ICH-GMP and ISO 9001 certified marijuana producer in North America. (MEDFF) has seen its stock climb nearly 50% since the launch of the first topical marijuana cream in the country on October 4th.

Continue reading
0 Comments

Emblem Corp. (EMMBF) Receives Health Canada License to Sell Cannabis Extracts

Emblem Receives Health Canada License to Sell Cannabis ExtractsEmblem Corp. (“Emblem” or the “Company”) (EMC.V), a vertically integrated health and wellness company focused on research, development, production and distribution of cannabis products for medical and pharmaceutical purposes, is pleased to announced that, effective November 3, 2017, the Company has been granted a license to sell cannabis oils. As announced on December 19, 2016, Emblem was initially granted a supplemental license for the production of cannabis extracts.

“Securing this license is an important milestone of our strategy to provide high quality, differentiated cannabis products, in a variety of formats. Our clients will be able to rely upon a selection of cannabis oils, including those from CBD dominant strains, THC dominant strains and strains with both CBD and THC content. Cannabis oils and related formulations provide a level of consistency and dosage accuracy that cannot be achieved with dried flower, and is a substantially more convenient and precise consumption method,” said John H. Stewart, President of Emblem’s Pharmaceutical Division. “We are very excited with the prospects this license brings, as we continue our clinical R&D initiatives towards unique cannabinoid delivery formulations, which we intend to introduce to the market in the future.”

Emblem anticipates announcing its updated product portfolio later this month, based on the addition of a range of cannabis oils, and commencing sales of its full product line shortly thereafter.

About Emblem

Emblem is licensed under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) to cultivate and sell medical cannabis. Emblem carries out its principal activities producing cannabis from its facilities in Paris, Ontario pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

For further information contact:Ali MahdaviEmblem Corp.(416)

Continue reading
0 Comments

Marijuana Stocks Top Stories – November 3, 2017

(CRPGF) Is Our New Connect The Dots Piece!

We Have Begun Coverage of Our Newest Long Term “Connect The Dots” Piece, (CRPGF)! Click HERE or Below!

Click Here for Instant Access!

Pennsylvania Registry Opens For Medical Marijuana PatientsPennsylvania’s Medical Marijuana Program became law on April 17, 2016. Now over a year later, its finally time for residents of the state to start the registration process. A six-month time period will be required to review applications for registration for the program by the state.

Click Here for Full Release

Continue reading
0 Comments

This Marijuana Stock Collapsed

More investors are placing their bets in marijuana stocks than ever before. With the average marijuana stock showing gains over 330% since the following year now we know why. A report titled the “Marijuana Business Factbook 2017″ predicts legal U.S. sales quadrupling to $17 billion by 2021. This would imply that the marijuana sector will continue to gain around 25 percent per year.

Although 64% of Americans favoring national legalization. Attorney General Jeff Sessions and federal law that classifies marijuana as an illegal substance without acknowledging any type of medical benefit which contributes the sectors high volatility.

Last week the sector’s volatility reached Insys Therapeutics, causing the Securities and Exchange Commission to halt the stock’s trading on Thursday. Insys shares are roughly down 90% from previous highs, crushed by a scandal involving the company’s star drug, Subsys. The drug is a fentanyl sublingual spray that the Food and Drug Administration (FDA) approved as a treatment for breakthrough cancer pain.

Lawsuits claiming that the Insys management and marketing teams advertised Subsys to physicians for off-label use of pain management while paying bribes to physicians to boost the drug’s sales. The company’s founder John Kapoor, also was recently arrested and charged with engaging in conspiracies to commit racketeering, mail fraud, and wire fraud. Adding to the company’s predicaments, President Trump declared the opioid crisis a public-health emergency this Thursday which can induce stricter regulations hindering sales for Insys.

There may be a light at the end of the tunnel for Insys with its new oral dronabinol solution, Syndros. The drug is a synthetic form of tetrahydrocannabinol (THC), the psychoactive component of cannabis, has been approved for the treatment of nausea and vomiting associated with chemotherapy and anorexia related to AIDS. With no other drugs like it on the market, Syndros could generate sales over $200 million annually. The only question now is whether Syndros will come to the rescue or will Insys go down in flames?

Continue reading
0 Comments

Pennsylvania Registry Opens For Medical Marijuana Patients

Pennsylvania’s Medical Marijuana Program became law on April 17, 2016. Now over a year later, its finally time for residents of the state to start the registration process. A six-month time period will be required to review applications for registration for the program by the state.

This isn’t just good news for patients. The application process is now open to doctors, caregivers, growers, and dispensaries as well. A vital goal of the state was to harvest a large amount of support among licensed physicians since without their support patients would not be able to obtain the medication. Pennsylvania’s Health Department has reported approving more than 100 physicians and hundreds more are awaiting the required training.

Two growing companies have been approved by the state with another ten not far behind. The only thing state has not done yet is approve dispensaries.

How do you sign up?

Firstly, you must qualify meeting one of the possessing one of the 17 medical conditions the state has approved of. A state created website is where a qualifying resident can create their profile. From there, only approved doctors can verify if the patient has a qualifying condition in which medical marijuana can be recommended.

Once the recommendation is obtained, the patient then registers for a medical marijuana ID card priced at $50. Cards will not be issued until May when approved dispensaries officially open.

Continue reading
0 Comments

Marijuana Stocks Top Stories – November 2, 2017

The Clock’s Ticking – Have You Connected The Dots Yet?There’s a reason you’re reading this. It’s because you’re looking for info on marijuana stocks and right now you couldn’t be in a better place. We’ve just released our newest Connect the Dots piece. This has been an elite segment for MarijuanaStocks.com readers and for good reason…these companies have come through BIG on all angles. Big developments, Big news, and even Bigger Gains. 11,303%…That is the combined gain percentage of the company’s we have profiled in our Connect the Dots segment plus our Canadian Stocks Highlight segment since 2014.

THIS ONE COMPANY has just scratched the surface as far as potential in concerned, in our opinion and it all comes down to timing.

Click Here Now!

Our Connect the Dots Piece Has Been Released!We Have Begun Coverage of Our Newest Long Term “Connect The Dots” Piece! Click HERE or Below & Begin Your Research Right Now!

Click Here for Instant Access!

Continue reading
0 Comments

PotNetwork Holding, Inc. (POTN) Reports Third Quarter Revenues of $4,444,800.00, Exceeding Second Quarter Results by 29%

PotNetwork Holding Reports Third Quarter Revenues of $4,444,800.00, Exceeding Second Quarter Results by 29%

PotNetwork Holding, Inc. (OTC Pink: POTN) announced today that its wholly owned subsidiary, Diamond CBD, Inc., reported third quarter revenues of nearly 4.5 Million Dollars for the third quarter of fiscal 2017, realizing a net increase of 29% when compared to the second quarter’s income of $3,183,161.00.

“We are very pleased with this quarter’s results and forge ahead into the fourth quarter with strengthened anticipation once again,” excitedly stated Chief Executive Officer, Dr. Richard Goulding, MD.

PotNetwork recently announced that the Company had retained the auditing services of East West Accounting Services, LLC, a Public Company Accounting Oversight Board (PCAOB) registered CPA firm, to provide a methodical review and analysis for the audited verification of the Company’s recent monthly reported revenues.

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holding Inc: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiary, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Continue reading
0 Comments

Lexaria Bioscience Corp. (LXRP) Acquires 100% Ownership of Poviva Tea LLC

Lexaria Bioscience Acquires 100% Ownership of Poviva Tea LLCLexaria Bioscience Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has acquired 100% ownership interest in its majority-owned subsidiary Poviva Tea, LLC.

Lexaria previously owned 51% interest in Poviva Tea, LLC and has acquired the remaining 49% interest. The acquisition consolidates ownership of Poviva Tea, LLC as a wholly owned Lexaria Bioscience subsidiary and simplifies future operations and certain intellectual property ownership. Compensation was US$70,000, a waiver on certain debts, and a 5%, 20-year royalty on net profits of ViPova TeaTM tea, coffee, and hot chocolate sales. No Lexaria stock or options were issued.

“This acquisition strengthens Lexaria’s intellectual property positioning and we reaffirm our commitment to the ViPova Tea product lines,” said Chief Executive Officer Chris Bunka. “Lexaria thanks the founders of Poviva Tea, LLC for their assistance and vision in this transaction.”

Lexaria’s patented DehydraTECH™ technology is focused on improved delivery methodologies of many commonly used Active Pharmaceutical Ingredients (“APIs”) substances. As such, it provides an additional layer of effectiveness that is designed to harmonize with the intellectual property of third parties. Both patented and generic API substances can utilize Lexaria’s patented technology. Lexaria’s long-term strategy is to partner with the world’s leading firms as they deliver best-of-class products to their existing large consumer groups.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

Continue reading
0 Comments

Insys Therapeutics, Inc. (INSY) to Host Earnings Call

Insys Therapeutics, Inc. to Host Earnings CallInsys Therapeutics, Inc. (NASDAQ: INSY) will be discussing their earnings results in their Q3 Earnings Call to be held on November 2, 2017 at 8:30 AM Eastern Time.

To listen to the event live or access a replay of the call – visithttps://www.investornetwork.com/company/24442.

To receive updates for this company you can register by emailing  or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

Continue reading
0 Comments

Legal Medical Marijuana Passes in Peru

On Thursday, Peru’s conservative Congress passed a bill to legalize medical marijuana. The vote was a landslide at 68-5 in favor of allowing oil from the plant to be produced, imported, and commercialized. This movement for legal marijuana stemmed from Peruvian mothers that wanted access to safer medicine.

Ana Alvarez, a mother of four from Lima, converted part of her home into a cannabis laboratory. Ms. Alvarez also takes informal visits from other patients and prescribes them marijuana derivatives to help curb debilitating conditions. Ms. Alvarez’s passion started when her son Anthony was suffering from multiple daily seizures. Cannabis was the only solution to stopping the seizures. That was when Ana decided to start helping others heal in Peru.

Ana talked about her son’s experience with cannabis, “After three days of taking marijuana oil, Anthony started to reconnect with life, he began to socialize, he began to sleep, he began to eat and little by little he started to recover,” she said. “The change after three days was something extraordinary and from that moment my fight began.”

Ana was not alone with her fight, Dorothy Santiago’s five-year-old son was suffering from the same conditions as Anthony. Ana and Dorothy decided to form Buscando Esperanza (Searching for Hope), which advocates for medical marijuana. The group has grown to over 200 members. Buscando Esperanza and others have protested in favor of legalizing medical marijuana. The group protested outside the Interior Ministry in Lima, Peru earlier in the year, One supporter had a sign that said, “give me back my medicine, do not let me die.”

Following a police raid on a Buscando Esperanza lab, President Pablo Kuczynski proposed a new measure to legalize medical marijuana. This bill was passed at 68-5 in favor of allowing cannabis oil, not flowers, to be grown and distributed for medical purposes. Lawmaker Alberto Belaunde stated that regulations would be written within 60 days. The new rules will establish how cannabis oil should be produced and commercialized. Alberto commented, “Thousands of patients and their family members will have hope and a better quality of life.”

Continue reading
0 Comments

Hemp, Inc. (HEMP) Announces Delivery of Advanced CBD Hemp Oil Extraction Post Processing Equipment

Hemp, Inc. Announces Delivery of Advanced CBD Hemp Oil Extraction Post Processing EquipmentHemp, Inc. ( OTC PINK : HEMP ), a global leader in the industrial hemp industry with the largest multi-purpose industrial hemp processing facility in the western hemisphere, announced today it has received all brand new, state-of-the-art components of the cannabidiol (CBD) post processing equipment to complete the Company’s hemp oil extraction infrastructure (Division 2). The latest equipment additions to the Company’s extraction operation will be assembled in the coming days.

“We chose the most cutting edge, state-of-the-art processing equipment on the market, from Across International, to ensure our CBD extracts lead the industry in quality and consistency, allowing us to bring innovative bulk CBD products to market. We have also partnered with Across International to display this state-of-the-art equipment at our Hemp University educational symposiums in the upcoming year. This equipment allows us to ‘winterize’ the raw CBD crude oil. After the CBD crude oil is winterized, we are able to perform the remaining post processing so that we can make an array of products, including but not limited to tinctures and cartridges to put it in vape pens… our options are limitless with this equipment,” said David Schmitt, COO of Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC.

In August, Hemp, Inc. announced the official launch of its NuAxon Tech CO2 Supercritical Extractor.

“The completion of our hemp oil extraction infrastructure will allow us to ramp up production of CBD products, creating increased Company value for the public and shareholders.” said Hemp, Inc. CEO Bruce Perlowin. “The market price of CBD crystalline isolate was commonly $20,000 per kilogram at the early part of 2017. While prices have gone down this year, in some cases, to as low as $6,500 per kilo on the low end volume price, CBD full spectrum extract making customized formulas have in some cases gone up and other cases gone down. Whether the price decreases or increases, I think it’s important to note and remind our shareholders that while we expect significant returns from our hemp oil extraction, it’s a secondary component of our overall business plan that we added to ‘enhance’ our revenues. Hemp, Inc.’s primary business is focused on producing non-toxic loss circulation material (LCM) and spill absorbents for the oil and gas industries.”

In oil or gas well drilling, “loss circulation” occurs when drilling fluid flows into one or more geological formations instead of returning up the annulus. “Loss circulation” can be a serious problem during the drilling of an oil well or gas well. Hemp, Inc., as mentioned in a previous press release, has a provisional patent that covers Hemp, Inc.’s process of dramatically reducing the time, cost, and energy required to create LCMs and spill absorbents using natural plant materials – resulting in a higher quality product for the oil and gas industries.

“Aside from our LCMs, we look forward to showcasing how our new, state-of-the-art post processing CBD equipment at our first 2018 Hemp University educational symposium. Our Hemp University educational symposiums have been an overwhelming success and they’re growing. We had to stop selling tickets at the last symposium because we were over capacity. We originally planned for only 100 attendees but there were over 140 people in attendance. We’re expecting the number of attendees to double at the next symposium, scheduled for December 2, 2017. Of course, we plan to hold it at a much larger venue. We strongly encourage you to buy your tickets early. We will definitely sell out and this isn’t marketing hype,” says Perlowin. “The hemp educational infrastructure we provide through ‘The Hemp University’ is delivering on our goal to make America great again by making America hemp again. We are teaching farmers, landowners, investors and entrepreneurs how to create a profitable income stream by maximizing their per-acre crop revenue.”

Continue reading
0 Comments

Connect The Dots: CNRP Mining Inc. (CRPGF)

MarijuanaStocks.com has always made it a point to stay far ahead of the curve. When we see a hint of opportunity, we make sure to look into it and then focus on all angles of potential that could come with it.

About 2 months ago we began to talk about a company who’s name didn’t give it justice but due to the fact that there was an LOI on the table, it couldn’t be overlooked. Now, the company’s most recent news release has pointed out a definitive agreement for a MAJOR ACQUISITION

CNRP Mining, Inc. (CRPGF) Announces Definitive Agreement for Acquisition of X-SPRAYS that will Give them EXCLUSIVE WORLD-WIDE LICENSING to an Existing line of CBD Infused Nutraceutical Products that are Already Being Sold! 

But what was just announced on October 25 could be exactly the signal that we’ve been looking for and here’s where we think a lot more people are going to start connecting the dots.

(CRPGF) announced that further to its press releases of July 21, 2017 and August 22, 2017 it has entered into a share exchange agreement dated October 24, 2017 to acquire all of the issued and outstanding shares of 1127466 B.C. Ltd. which holds, through a wholly owned subsidiary, a world-wide, exclusive license for X-SPRAYS – a brand of state-of-the-art life-enhancement products administered via an optimal oral spray delivery system.

Continue reading
0 Comments

22 Year Old Cashes In On Marijuana Stocks And Now Sells Works of Art

A twenty-two-year-old artist, Ben Milstein, has entered the rapidly growing marijuana industry. Milstein contributes his earlier success in the marijuana industry from seeking an investment opportunity when a friend suggested marijuana stocks a few weeks before legalization in the state Colorado, and then stocks ran.

Now, Milstein creates extravagant, hand-blown glass pipes and bongs which sell for up to six figures. Yes, six figures.

“I’m not selling bongs — I’m selling works of art,” Milstein said in an interview.

Millstein’s company dubbed Grey Space Art, hosts pop-up galleries throughout the major cities across the country. His private collection now contains over 500 pieces made by over 75 different artists. This collection, which Millstein said he will not sell, because as he said demands “to be seen by more people,” and also because over the last two years the collection has tripled in value.

“There’s a reason why I’m in this industry and not buying wall art. It’s about the momentum of the cannabis industry,” Milstein said.

Continue reading
0 Comments

Nevada Reports $33M In August Marijuana Sales

Nevada reports impressive numbers for its second month of recreational marijuana sales. Numbers don’t lie, especially from Nevada’s Department of Taxation.

During the month of August, dispensaries reported selling more than $33 million of medical and recreational marijuana. Recreational marijuana was legalized for the state in September, when it brought in a record-breaking $27 million surpassing the states of Colorado, Washington and Oregon during their first month. In month two of recreational sales, there was a 22% increase or $6 million generated in sales. This allowed the Department of Taxation to deposit somewhere around $5 million in tax revenue into the states emergency fund.

“I think it is a good indication that there was a large, pent-up demand that was being served by the black market,” said Andrew Jolley, president of the Nevada Dispensary Association.

Governor Brian Sandoval had previously believed that Nevada would generate about $100 million in taxes and fees during a two year period. But now, the state’s officials are anticipating a significantly larger number closer to $120 million given the current sales.

August’s numbers confirm that Nevada outperformed Colorado by more than double during its second month of operation and nearly seven times more than Washington. It is unknown how Nevada will measure up to California, whose market could be worth $5 billion, when it commences recreational legalization early next year.

Continue reading
0 Comments

Do You Understand Marijuana Stocks? Morning Update – October 26, 2017

A New Connect the Dots Is Coming!

We’re giving you fair warning that we will be deilvering our next Connect the Dots feature next week!

Just to give you a refresher, remember this number: 11,303%…That is the combined gain percentage of the company’s we have profiled in our Connect the Dots segment. In preparation to close out October and kick-start November with a bang with a full report on on Monday, October 30, 2017. If you’re not familiar with our Connect The Dots pieces, we suggest you click the following link to get up to speed. And remember, our next Connect The Dots piece will be delivered by Monday, October 30, 2017.

Click Here To Read More!

Understanding Marijuana Stocks Made Easy

Continue reading
0 Comments

Tetra Bio-Pharma Inc. (TBPMF) Goes After the Cannabis Oil Medical Market

Tetra Bio-Pharma Goes After the Cannabis Oil Medical Market and Launches a Phase 4 Trial with Cannabis Oils in Partnership with Santé CannabisTetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced the launch of a medical cannabis oil program as it targets penetrating the lucrative cannabis oil market and strengthens its plans to generate revenues from the medical cannabis market.

Last year Tetra launched several drug development programs to commercialize cannabis-based prescription drugs making it one of the world leaders in cannabinoid pharmaceuticals. Tetra’s vision is to develop an evidence-based approach similar to that of any other prescription drug, thereby allowing physicians and pharmacists to prescribe and dispense these medicines to patients in need. Despite the growing popularity of cannabis oils, physicians and pharmacists across Canada are hesitant to support the use of these products because of the lack of data supporting its medical use; even though healthcare professionals have to offer the best available care to patients, they also need to ensure that the treatment dispensed by pharmacists does no harm.

Since 2015, the Canadian cannabis oil market has grown from below 600 kg in the first quarter (Jan-Mar) of 2016 to over 6000 kg in the same first quarter of 2017, and it is expected that this market will continue to show significant growth according to a July 26, 2017 report by Eight Capital. Based on an estimated average sales price of $75-100 per 60 ml for cannabis oil, the 2017 global cannabis oil sales in Canada could exceed 30 million dollars.

According to Tetra’s Chief Executive Officer (CEO), Bernard Fortier,” Tetra is in a good position to penetrate this market. We have been preparing for months how to differentiate ourselves within this market while maintaining our corporate vision of an evidence-based approach. The cannabis oil market will be no different for Tetra. The corporation is dedicated to providing evidence and supporting physicians and other healthcare professionals while making cannabis accessible to their patients. We are on target to initiate our sales strategy by March 2018 to carve out a solid position within the Canadian market. We expect to generate revenues in the cannabis oil market in 2018 and we will grow these revenues as physicians become aware of our scientific approach and patient care programs. Based on a conservative market penetration estimate, we are targeting to grow our share of the cannabis oil business to over 1 million in revenues by 2019.”

Furthermore, Tetra is announcing that it is supporting a post-marketing study (phase 4 clinical trial) of the use of cannabis oil in the treatment of chronic pain. This trial is driven by the medical experts of Santé Cannabis and will provide much needed safety and efficacy data in this patient population. Tetra will be supporting Santé Cannabis in this important endeavor with its internal regulatory and scientific team. Data generated by this study will help Tetra’s medical team in educating physicians on the potential of cannabis oils to treat patients suffering from chronic pain. Once completed, this trial will allow Tetra to penetrate even further into the cannabis oil market making it one of the key players as it continues to grow its share of this over 30-million-plus dollar market.

Tetra’s scientific team is also supporting the sales strategy by initiating a safety and pharmacokinetic study in healthy volunteers (phase 1 clinical trial) to characterize the safe use of these cannabis oil medicines in humans. Combined with the study in patients suffering from chronic pain, Tetra will have a solid and credible position in the medical cannabis oil market. Dr. Chamberland, Tetra’s Chief Scientific Officer (CSO), commented that” physicians are concerned about the potential side effects and well-being of patients using cannabis oil. It is this type of data that continues to allow Tetra to differentiate itself in the medical cannabis market as we become leader in the field. Over and over, physicians and pharmacists welcome the pharmaceutical approach used by Tetra as it is a proven model for bringing safe and efficacious therapies to patients. Patients are expecting their healthcare professionals to treat cannabis like a medicine and help ensure that they safely consume these products. This expectation from patients will soon be fulfilled by Tetra’s strategic approach to patient care.”.

Continue reading
0 Comments

Future Farm Technologies Inc. (FFRMF) to Acquire a Controlling Interest in Five Dispensaries

Future Farm to Acquire a Controlling Interest in Five DispensariesFuture Farm Technologies Inc. (the “Company” or “Future Farm”) ( CSE : FFT ) ( OTCQB : FFRMF ) is pleased to announce a new joint venture between Future Farm and TCG Investments, LLC, owners of the Clinica Verde brand of medical cannabis dispensaries (“Clinica Verde”). Future Farm will purchase five pre-qualifications for medical dispensary licenses from Clinica Verde (“Licenses”). Subsequently, the Licenses will be contributed into a joint venture company that will operate five medical cannabis dispensaries in Puerto Rico under the Clinica Verde brand. Clinica Verde has already established itself as the leading medical cannabis dispensary operator in Puerto Rico, with five additional operating dispensaries.

Link To Clinica Verde Dispensaries: Clinica Verde Homepage

Future Farm has been working for several months on this exciting opportunity to own an interest in five dispensaries, which have the potential to provide consistent cash flow. While Hurricane Maria’s devastation to the island was cause for concern, Future Farm remains committed to helping its partners expand their dispensary presence in order to provide the people of Puerto Rico with a reliable source of medical marijuana, as well as continuing to create a diversified portfolio of cannabis investments for Future Farm’s shareholders. Future Farm looks forward to contributing to the expansion of the medical cannabis industry, which is a key driver for the future economic development of Puerto Rico.

“Our existing stores are located in high-traffic locations and ever since our launch in February we have enjoyed sustained sales growth. We look forward to expanding our presence to 10 stores in Puerto Rico, creating jobs and offering our patients the highest level of service,” says Ramón Ortiz, CEO of Clinica Verde. “The patient registration process was recently simplified and is now quicker and more accessible to all. We believe we will be able to start building out the new dispensary locations this year and look forward to a Q1 2018 opening.”

Medical marijuana is legally used in Puerto Rico to address more than a dozen conditions, including Alzheimer’s, cancer, Lou Gehrig’s disease, Parkinson’s, rheumatoid arthritis, Crohn’s disease, epilepsy and more. On October 6th, Puerto Rico’s Department of Cannabis’ board approved allowing patients to go to any open clinic, regardless of the dispensary they had been assigned. The new rule lasts until two weeks after the state of emergency has ended or until the board decides to terminate it.

“We’re pleased about the revenue opportunities these five major dispensaries open up to us as we provide medical marijuana patients with legal, consistent, pure flower, edibles and concentrates,” says Bill Gildea, CEO of Future Farm Technologies. “Puerto Rico, with a population of almost 3.5 million residents and another 4 million annual visitors, is an exciting, new market for Future Farm.” The local population compares well to other states that have legal cannabis. By way of example: Colorado has a population of about 5,540,545, Utah 3,051,217, Arizona, 6,931,071 and Nevada has 2,940,058.

Continue reading
0 Comments

Understanding Marijuana Stocks Made Easy

Marijuana stocks, the financial industry’s best kept secret until recent times. Far gone are the days where you had to be a day trader or work in the financial industry to get ahead in the stock market. The marijuana industry’s valuation has reached roughly $7 billion and is continuing to grow at rapid rates. With the marijuana industry still in its developing stages, now is the time to get ahead and begin investing in the companies in the marijuana market. This is where the phrase, “the early bird catches the worm” applies.

Moving on to categorize some of the different publicly traded divisions of the marijuana industry.

Category 1- Growers/Suppliers

Without the growers, there is no product. As with any other type of industry in their beginning stages, the manufacturer is of high importance. Makes sense, right?

In Canada, there is ample opportunity for this business category. The country had legalized medical marijuana back in 2001 and is now moving towards full legalization, or legalizing the recreational use, as soon as July of 2018. To control the anticipated increased demand for the product a surge of growers has emerged.

Continue reading
0 Comments

Is The Marijuana Market In The U.S. To Much Of a Risk For Canadian Firms

Canada’s security regulators are waving red flags about Canadian marijuana companies doing business in U.S. states which have legalized use of marijuana, and legal experts have pointed out such companies that could risk being delisted from the nation’s stock exchanges if they started or continued to operate on the other side of the map

The Canadian Securities Administrators (CSA) issued a staff notice Oct. 16 which goes over a series of disclosure expectations for those who have concerns with U.S. marijuana-related activities.

Noting marijuana use is still illegal under U.S. federal law, these expectations include a much more stern approach to disclosing rules that present all material facts, risks, and uncertainties with regard to U.S. operations, including stating whether or not the operations are conducted in a manner consistent with U.S. federal enforcement policies and discussing the issuer’s ability to access both private and public capital given the illegality of marijuana under U.S. federal law.

Huston Loke, director of corporate finance at the Ontario Securities Commission (OSC), noted: “companies with marijuana-related activities in the U.S. assume certain risks due to conflicting state and federal laws.”

“We expect companies to clearly and prominently disclose these risks to investors, including risks that result in changes in the approach to enforcement of U.S. federal law,” he said. “To ensure companies are clear on the level and type of disclosure we expect, the CSA published a staff notice that sets out our disclosure expectations.”

Continue reading
0 Comments

Will St. Louis Pass Bill Allowing the Use, Sale and Growth of Marijuana

Earlier this week, a new bill sponsored by Alderwoman Megan Green, has been proposed to permit the growth, sale, and use of marijuana in St. Louis. The main goal of the bill is to make valuable time more available for law enforcement officials for actual victims of crimes, according to the St. Louis Post Dispatch.

It would be illegal for St. Louis to enforce laws allowing “the civil or criminal punishment for the use or possession of marijuana or marijuana paraphernalia against any individual or entity” with the new bill. Yet, there are penalties for instances such as using or selling marijuana under the age of 21 and consumption will likely be restricted to private residential property.

Missouri and St. Louis don’t see eye to eye on marijuana usage. Missouri has yet to decriminalize marijuana in the state, not even for use for medicinal purposes. Recently, minor changes have been made to the states marijuana regulations in terms of possession. Jail time has been excluded for first time offenders that were convicted of possessing less than 10 grams of weed.

The Board of Aldermen had passed a similar law that lessened penalties for those caught with minute amounts of marijuana back in 2013. “I think this is a good step for the city of St. Louis,” Alderman Shane Cohn stated at that time. “It doesn’t legalize marijuana, but it gives fairness.”

The current law imposes a fine anywhere from $100 to $500 for a small possession. It provides officers an option to order court summons for first and second time offenders that possess less than 35 grams of weed, reducing criminal cases. Prior to this a first-time offender that was caught with up to 35 grams was charged with a misdemeanor followed by up to a year in jail and a $1,000 fine.

Continue reading
0 Comments

Marijuana Stocks Are Rapidly On The Rise

Whether you are a supportive advocate of legalizing marijuana or not there is no denying that the cannabis industry is certainly real and here to stay. Currently, the stock market is at an all-time high and several marijuana stocks have made market returns look pedestrian.

Would it come as a surprise if you were to find out that cannabis is the United States is recognized as the second largest cash crop? Well, believe it or not, it actually is as well as the second most precious industry next to corn and is worth over $40 billion! Several reports earlier this year also suspect that legal marijuana sales have the potential grow by at least 30% in 2018.

The marijuana industry is predicted to grow like a weed. (pun intended). All jokes aside, the Bureau of Labor Statistics (BLS) has made a projection that more than 250,000 new employment opportunities for those who are looking to get involved and this could be accomplished as early as 2020 which is far more than those expected from manufacturing! By 2024 the BLS actually thinks manufacturing jobs to decline by 814,000. Ignoring the potential growth in this industry or that it has fast become a major economic driver and job-creation force in the U.S. economy is a mistake.

Public opinion is still divided which doesn’t come as a shocker however it’s quickly evolving. A poll that was conducted by CBS News in July of 1979 showed that only 27% of those who completed a survey thought marijuana should be legal; that number by mid-2017 is now at 61%. Even with this momentum there still remains some obvious hurdles: (1) Marijuana is still illegal at the Federal level and (2) Congress has more than enough to focus on right now with healthcare and tax reform so legalization is a lower priority for now.

The post Marijuana Stocks Are Rapidly On The Rise appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

Enertopia Corporation (ENRT) Provides Lithium Bench Test Update

Enertopia Provides Lithium Bench Test UpdateEnertopia Corporation (ENRT) (CSE:TOP) (the ”Company” or ”Enertopia”) is pleased to announce the following bench testing update for the recovery of Lithium and ultimately, upgrading the Lithium to battery grade Li2CO3 by our technology partner Genesis Water Technologies Inc., (GWT) a global leader in specialized water treatment solutions.

The goals of this much larger second phase bench test are to build upon the first phase results and achieve lithium recovery rates of greater than 80% with Li2CO3 achieving minimum purity of 99.5% with battery grade standards being achieved.

Genesis Water Technologies (GWT) has provided Enertopia with the following update summary:

The completed milestones include process & flow diagram of the system processes. After this initial concept review with a presentation of initial diagrams, the design calculations have commenced for the whole process. This process has included using several calculations and formulas relating to chemistry, chemical engineering, process design, leach method calculations for various pH adjustment scenario’s and process control volume for tanks.

This has been followed by electrical engineering calculations pertaining to faradays equations, wire diagrams for the systems themselves pertaining to all processes for both electrolysis process and the ion exchange process chemistry. November will start the initial testing of Leach Samples to determine yield into leach solutions.

Overview of 3rd party laboratory results from the bulk samples to be used in the bench testing below:

Continue reading
0 Comments

Medical Cannabis Extracts Ruled Illegal by Arizona Judge

Arizona state law states that there is a difference between marijuana and cannabis. When Arizona residents voted for instating a medical marijuana program, the term “marijuana” referred to the medicine in flower form “and any mixture or preparation thereof.” Lawmakers wrote the definition of “cannabis,” however, in the criminal code before 1960. Cannabis is viewed as a narcotic derived from marijuana.

The law specifically focuses on the resin that can be pressed out of the flower. It extends to all of the products made from the resin, the vape pen cartridges and concentrates. However, the resin that is legally called cannabis, is somehow not marijuana. Earlier in the month, Arizona courts ruled that Medical Marijuana Act did not cover extracts because the law considers them “cannabis.” The extracts in question include wax, resin, oil, and tinctures.

Many problems have occurred for medical marijuana patients in Arizona. Due to the criminal code definition, a lot of forms of medical marijuana are technically illegal. Even CBD extracts, which are used to treat seizure disorders, remain in a grey area. Regardless of the legal technicality, dispensaries in Arizona sell medical marijuana products made from “cannabis.” These product include the typical vape pens, tinctures, oils and concentrates that you would expect a dispensary to sell. As of now, there’s no indication that Arizona medical dispensaries will stop selling these products.

The law mostly affects medical card holders, like the people who rely on medicinal weed to alleviate their various ailments. If the police pull over an Arizona resident with a valid medical card, if the card-holder posses a vape pen, wax or any other “cannabis” product, the police could arrest them and file charges.

The ruling in Arizona is worrying, not because it will likely shut down dispensaries and take products off the shelves, but because it indicates that in the state of Arizona, the criminal code does not accurately reflect scientific advancements and studies. Appeals courts and cannabis lawyers have mostly had success in individual cases pertaining to concentrates and extracts. The fact remains that in order to actually protect people, the state will need to update the law better to reflect current terminology and facts.

Continue reading
0 Comments

Cara Therapeutics, Inc. (CARA) Doses First Patient in Phase 1 Study of Oral CR845

Cara Therapeutics Doses First Patient in Phase 1 Study of Oral CR845 in Non-Hemodialysis Chronic Kidney Disease PatientsCara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today announced that it has dosed the first patient in its Phase 1 pharmacokinetic and safety trial of Oral CR845 tablets in patients with stage III-V chronic kidney disease (CKD) who are not on dialysis. According to estimates from the Centers for Disease Control and Prevention, approximately 15 percent of the adult population in the United States, or 30 million people, suffer from CKD, with an estimated 50 percent in stages III-V.1 Of the patients diagnosed with stage III-V CKD, approximately 25 percent suffer from moderate-to-severe pruritus.2,3

“We are pleased to move Oral CR845 forward into non-hemodialysis patients with earlier-stage CKD,” said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer of Cara Therapeutics. “Given the highly encouraging data we’ve achieved to date with I.V. CR845 in hemodialysis patients with moderate-to-severe pruritus, we believe Oral CR845 has the potential to substantially broaden our market potential in patients with CKD-aP.”

Phase 1 Trial Design

The Phase 1 trial is designed to examine the pharmacokinetics and safety of three tablet strengths of Oral CR845 (0.25 mg, 0.5 mg and 1.0 mg), dosed daily over a one-week treatment period in up to 80 non-hemodialysis patients with stage III-V CKD. Data from this trial will inform dose selection and design of a planned placebo-controlled Phase 2 trial of Oral CR845 in non-hemodialysis stage III-V CKD-aP patients, which the Company plans to initiate in the first quarter of 2018. The U.S. Food and Drug Administration previously granted Breakthrough Therapy designation to I.V. CR845 for moderate-to-severe CKD-aP in hemodialysis patients.

About CKD-aP

CKD-aP is an intractable systemic itch condition that occurs with the greatest frequency and intensity in patients with chronic kidney disease undergoing hemodialysis and peritoneal dialysis. Pruritus has also been reported in patients with stage III-V CKD who are not on dialysis. Recent data from the ITCH National Registry Study showed that among those with pruritus, 59 percent experienced symptoms daily or nearly daily for more than a year. Given its association with CKD/ESRD, most afflicted patients will continue to have symptoms for months or years with currently employed antipruritic treatments, such as antihistamines and corticosteroids, unable to provide consistent adequate relief. Moderate-to-severe chronic pruritus has repeatedly been shown to directly decrease quality of life, contribute to symptoms that impair quality of life (such as poor sleep quality), and is associated with depression. CKD-aP is also an independent predictor of mortality among hemodialysis patients, mainly related to increased risk of inflammation and infections.

Continue reading
0 Comments

Blue Line Protection Group, Inc. (BLPG) Grabs Top Spot as Leading Currency Processor for Colorado’s Cannabis Industry

Blue Line Grabs Top Spot as Leading Currency Processor for Colorado’s Cannabis IndustryBlue Line Protection Group, Inc.(BLPG) has become the leading currency processor for Colorado’s lawful cannabis industry, with nearly $250 million processed in 2017 and an expanding list of clients that includes Colorado’s largest legal cannabis dispensary, cultivation facility and manufacturing operations.

Blue Line serves state-licensed cannabis businesses with secure currency transportation and change fulfillment services and provides security, transportation and risk mitigation solutions for financial institutions servicing the legal cannabis industry.

Blue Line has surged past all other armored transportation and vaulting providers, making Blue Line the premier secure transportation and currency services provider for cannabis operations throughout Colorado.  “No other armored courier has fulfilled the needs of this cash-heavy industry as we have,” said Daniel Allen, Blue Line’s CEO.  “Our commitment to customer service and our ability to provide compliant currency transportation operations has made us the number one choice for cannabis cash movement for our bank and credit union partners.”

Since opening its secure vaulting and processing operations in October 2016, Blue Line has secured the industry’s leading legal cannabis clients across Colorado.  Blue Line has increased the number of locations serviced per month from just 124 in January to over 1,000 by the end of September 2017, increasing its transportation revenue by over 700 percent.

Blue Line experienced an increase of 472 percent in the monthly client currency deposits since January, processing over $83 million in August and September alone, and $242 million in its secure vaulting and processing facility thus far in 2017.  “We’re on track to process half a billion dollars over the next year for this industry in Colorado alone,” added Mr. Allen.  “We’ve seen a tremendous increase in the number of clients served by our transportation and currency processing services.  We’ve also seen strong revenue growth in 2017, with a nearly 500 percent increase in our processing revenue since January.”

Besides currency processing and transportation, Blue Line also saw continued growth in its coin, currency and ATM services, fulfilling over $17 million in currency order requests for its clients this year.  Revenue for providing these change and ATM fulfillment services jumped 350 percent since January.

Continue reading
0 Comments

Medical Marijuana Is Now Legal in Peru

This past Thursday, Peru’s conservative Congress passed a bill to legalize medical marijuana. The vote was a landslide at 68-5 in favor of allowing oil from the plant to be produced, imported, and commercialized. This movement for legal marijuana stemmed from Peruvian mothers that wanted access to safer medicine.

Ana Alvarez, a mother of four from Lima, converted part of her home into a cannabis laboratory. Ms. Alvarez also takes informal visits from other patients and prescribes them marijuana derivatives to help curb debilitating conditions. Ms. Alvarez’s passion started when her son Anthony was suffering from multiple daily seizures. Cannabis was the only solution to stopping the seizures. That was when Ana decided to start helping others heal in Peru.

Ana talked about her son’s experience with cannabis, “After three days of taking marijuana oil, Anthony started to reconnect with life, he began to socialize, he began to sleep, he began to eat and little by little he started to recover,” she said. “The change after three days was something extraordinary and from that moment my fight began.”

Ana was not alone with her fight, Dorothy Santiago’s five-year old son was suffering from the same conditions as Anthony. Ana and Dorothy decided to form Buscando Esperanza (Searching for Hope), which advocates for medical marijuana. The group has grown to over 200 members. Buscando Esperanza and others have protested in favor of legalizing medical marijuana. The group protested outside the Interior Ministry in Lima,Peru earlier in the year, One supporter had a sign that said, “give me back my medicine, do not let me die.”

Following a police raid on a Buscando Esperanza lab, President Pablo Kuczynski proposed a new measure to legalize medical marijuana. This bill was passed at 68-5 in favor of allowing cannabis oil, not flowers, to be grown and distributed for medical purposes. Lawmaker Alberto Belaunde stated that regulations would be written within 60 days. The new rules will establish how cannabis oil should be produced and commercialized. Alberto commented, “Thousands of patients and their family members will have hope and a better quality of life.”

Continue reading
0 Comments

Damian Marley’s New Line of CBD Products

Damian Marley, the youngest son of Bob Marley, has announced that his company is launching a hemp-derived CBD product line. Damian Marley’s CBD products will be available online and in select dispensaries across the nation.

Marley and Ocean Grown Extracts collaborated and converted an abandoned prison in California into their marijuana growing site. The company, dubbed Stony Hill, is working with doctors and scientists to continue to educate the public about the benefits of marijuana, as the nation leans more towards the acceptance of marijuana’s therapeutic properties. Stony Hill’s CBD formulas were created to target a broad range of conditions and the company believes its CBD brand can benefit just about anyone.

You can purchase Stony Hill’s line of gummies, topicals, and solutions through the company’s e-store. The organic CBD gummies are available in both a day and night formula, the night formula has added melatonin to assist with sleep. The all-natural CBD topical lotions are scented with essential oils and absorb rapidly to combat pain and inflammation. The line also presents hemp-derived CBD solutions in a different range of potencies. In the future, Stony Hill plans to launch product lines in both specialty and retail stores.

Chris Bridges, president of Stony Hill, stated, “According to the Hemp Business Journal, the hemp-derived CBD products market is expected to surpass $450 million by 2020, and we are pleased to be getting involved during the industry’s infancy. With the overall CBD market expected to surpass $2.1 billion by 2020, we feel strongly that the legalization and availability of hemp-based products stand to attract the lion’s share of the market as cannabis-based CBD products overcome the federally imposed hurdles.”

JJ Southard, Stony Hill’s vice president, added: “It is important for consumers to be educated on the differences between hemp-based CBD and cannabis for multiple reasons including efficacy, legality and safety. Hemp-derived CBDs provide an attractive alternative for people looking to reap the medical benefits of cannabis, but who cannot obtain cannabis due to legality issues or simply do not want to experience the psychoactive effects of THC.”

Continue reading
0 Comments

Marijuana Stocks Breaking News & Articles – October 24, 2017

GT Biopharma Inc. (GTBP) Announces Approved FDA IND Transfer of Its First TriKE (OXS-3550)

GT Biopharma Inc. (OTCQB:GTBP and Euronext Paris GTBP.PA) announced today the FDA has accepted the transfer of IND 136205 Change of Sponsor from the University of Minnesota to GT Biopharma for a commercial IND of OXS-3550 (anti-CD16-IL-15-anti-CD33); a first of its kind, single-chain, tri-specific NK cell engager (TriKE).

Click Here To Read More

Marijuana Stocks: Connect the Dots + Canada = +11,000% Gains…We’re Not Exaggerating

11,303%…That is the combined gain percentage of the company’s we have profiled in our Connect the Dots segment plus our Canadian Stocks Highlight segment since 2014. And we’re not exaggerating one bit.

Continue reading
0 Comments

Reliq Health Technologies Inc. (RQHTF) CEO, Dr. Lisa Crossley, to Present at StableView TECH17

Reliq Health Technologies CEO, Dr. Lisa Crossley, to Present at StableView TECH17Reliq Health Technologies Inc. (RHT.V) (RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that the Company’s CEO Dr. Lisa Crossley will be presenting at the StableView Asset Management TECH17 Conference in Toronto, ON on Thursday, October 26, 2017 at 10:45am.

“We are excited to be a part of StableView’s annual conference and look forward to sharing our progress and business plan for growth with attendees,” said Reliq Health CEO, Dr. Lisa Crossley.

About StableView TECH17

StableView Asset Management hosts StableView TECH17.  The 4th annual StableView TECH17 showcases the most innovative ideas, themes and challenges in Technology today.  As the only buy-side curated tech conference in Canada, StableView TECH17 sits at the junction of the public and private investing tech ecosystem in Canada and brings together participants that typically stay in their individual silos: institutional investors, pensions, VCs, broker-dealers, advisors, HNW investors and family offices with private and public tech companies in Canada.

On October 26th, 2017, approximately 25 of Canada’s leading technology companies will be presenting to an expected audience of over 450+ professionals representing approximately $350B in AUM.

About Reliq Health Technologies

Continue reading
0 Comments

GT Biopharma Inc. (GTBP) Announces Approved FDA IND Transfer of Its First TriKE (OXS-3550)

GT Biopharma Announces Approved FDA IND Transfer of Its First TriKE (OXS-3550)GT Biopharma Inc. (OTCQB:GTBP and Euronext Paris GTBP.PA) announced today the FDA has accepted the transfer of IND 136205 Change of Sponsor from the University of Minnesota to GT Biopharma for a commercial IND of OXS-3550 (anti-CD16-IL-15-anti-CD33); a first of its kind, single-chain, tri-specific NK cell engager (TriKE).

OXS-3550 TriKE technology was developed by researchers at the University of Minnesota Masonic Cancer Center. As demonstrated in non-clinical models, this targeted immunotherapy directs immune cells to kill cancer cells while diminishing drug-related toxicity.

Several months ago, the GT Biopharma TriKE platform technology received funding from the University of Minnesota’s National Institution of Health (NIH) REACH award. This award is given by the NIH to support technology that is promising for commercial success.

The TriKE platform technology can be viewed as a protein version of CAR-T. However, unlike traditional CAR-T platforms like Kite Pharma (KITE) and Juno Therapeutics (JUNO), TriKEs are not an expensive cell therapy currently only available to treat liquid tumors. It is anticipated that TriKEs will be a therapeutic option for a much larger portion of the cancer population at a fraction of the cost. TriKEs are an antibody platform that can be tailored to treat any form of cancer, liquid or solid tumors.

The TriKE platform focuses on Natural Killer (NK) cells, a type of white blood cell, which plays a major role in the rejection of tumor and virally infected cells. NK cells are an important component of the innate immune system and are critical in killing cancer cells.

The TriKE IND (OXS 3550) will focus on AML, the most common form of adult leukemia with 21,000 new cases expected in 2017 alone (American Cancer Society). These patients will require frontline therapy, usually chemotherapy including cytarabine and an anthracycline, a therapy that has not changed in over 40 years. Also, about half will have relapses and require alternative therapies. In addition, about 13,000 new cases of myelodysplastic syndrome (MDS) are diagnosed each year and there are minimal treatment options (Siegel et al, 2014). At a minimum, OXS-3550 can be expected to serve as a relatively safe, inexpensive, and easy to use therapy for resistant/relapsing AML. From a biologic standpoint, it could also be combined with chemotherapy as frontline therapy.

Continue reading
0 Comments

PotNetwork Holding, Inc. (POTN) Brings to Market Tasty Honey Selections Including Featured Premium Organic CBD-Infused Honey Sticks

PotNetwork Holding, Inc. Subsidiary, Diamond CBD, Brings to Market Tasty Honey Selections Including Featured Premium Organic CBD-Infused Honey Sticks

PotNetwork Holding, Inc. (OTC Pink: POTN) is pleased to announce that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a delicious selection of premium honey products. Among these new products, the company will have delicious honey packed straws infused with 10mg of pure natural organic CBD.

With the potentially beneficial attributes of both cannabis and honey known for centuries, Diamond CBD’s highly anticipated Infused Honey Sticks may offer a whole new tasty way to enhance wellness and boost the immune system. Comprised of 100% full spectrum CBD and all natural honey, these delicious straws are expected to be a welcomed item providing enthusiasts with a practical and beneficial delivery method of nature’s gifts as revealed in studies in the Asian Pacific Journal of Tropical Biomedicine and available upon the inevitable opening of flu season.

Although THC remains a scheduled substance under current U.S. law, the paradigm is shifting and attitudes are changing towards cannabis as a result of recent research into the endocannabinoid system and the physical role it plays. Containing receptors that naturally respond to cannabinoids, the human body has, in numerous studies, shown to interact favorably, often enhancing the body’s natural ability to fight disease and reduce symptoms.

One of the major ingredients of cannabis, and the source of CBD rich hemp oil, cannabidiol has been formally recognized by the U.S. Patent Office as an “antioxidant and neuroprotectant.” Filed in 1999, and published in 2003, U.S. Patent 6630507 has recognized cannabidiol as an effective antioxidant. Antioxidants are generally useful in the treatment of oxidative diseases and are known for anti-aging effects. Treatment resistant ailments such as Alzheimer’s disease, Parkinson’s disease, and HIV dementia are mentioned in the abstract as potentially treatable with antioxidant CBD. Inflammatory and autoimmune diseases are also noted.

Recently announced, the Company has delivered yet another impressive month of financial and industry growth. For the month of August 2017, Diamond CBD achieved record breaking revenues of $1,764,880.00, which exceeded July revenues by 20.9%.

Continue reading
0 Comments

Maine to Delay Retail Cannabis Sales Until 2019

Although the state of Maine has voted to legalize the recreational use of marijuana, residents are still waiting for the law to come into effect. Maine’s Governor Paul LePage deems the current law is imperfect and is determined to postpone retail cannabis sales until 2019.

House Minority Leader Ken Fredette is supporting a new suspension bill on behalf of Governor LePage. Fredette said in a written statement, “This option provides legislators with the opportunity to deal with this issue during the regular legislative session which starts in January, rather than having a straight up or down vote on the bill put forward by the committee”. LePage has previously postponed portions of the new cannabis laws until February 2018 with LD 88 and is pursuing additional time.

The current bill required three months of preparation by a special Marijuana Legalization Implementation Committee. The bill did come with imperfections, an error that would allow cannabis possession to be legal for minors. “By not taking action and not responsibly writing the rules to get this up and going, the black market just perpetuates,” said Rep. Teresa Pierce and co-chair the committee.

Roger Katz, co-chair of the committee, stated “We wish the administration had been more involved in this process. We’ve spent a lot of time to put together a summary and talking points, so people know what’s going to be voted on”. The bill was suggested to pass by a 15-2 committee vote.

For Governor LePage to postpone retail cannabis sales, he’ll have to go through supporters of the bill. Advocates of the bill believe that any type of delay will allow illegal markets to flourish while the state gets it together. The delay brings on an extensive process by the executive branch, which then needs approval by the legislature. With this, the earliest Maine will see the full execution of recreational cannabis is 2019.

Continue reading
0 Comments

Is It Safe To Bring CBD Oil On An Airplane?

Now that use of recreational marijuana is legal in eight states, more people are finding themselves questioning what the law says about traveling with marijuana. Complicating matters, the TSA has issued somewhat uncertain measures about what is allowed and what is not allowed on flights. And most of the difficulty has to do with the status, not of dried flower, rather the oils, and concentrates. Take CBD oil, for example, some types of which are legal everywhere. Can you bring CBD oil on a flight with you? For the most part, yes.

Flying can be stressful. Even if the idea of hurtling through the environment in a steel bird doesn’t make your hands sweaty, the craziness of most airport terminals—the long lines for TSA screenings, the lost luggage, the irate travelers—is enough to fray anyone’s nerves.

As a result, many individuals have their own guilty pleasures that help with the anxieties and stress of air travel. It could be getting a buzz from a few drinks in an airport bar. Maybe it’s taking a medication. Perhaps, it’s getting extraordinarily stoned on marijuana.

But high-altitude and low pressure make the effects of these drugs somewhat unpredictable. Take for example the case of a Delta passenger who claimed in court that eating pot brownies made him freak out and attack flight attendants and passengers.

The point is, sometimes the high from marijuana edibles can be too much, making an already unpleasant situation—flying—worse. But cannabis can help reduce anxiety and stress without psychoactivity. Thanks to CBD, a cannabinoid that, unlike THC, won’t get you high.

Continue reading
0 Comments